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ABSTRACT OF THE DISSERTATION 
 
Multifunctional Neural Probes for Electrochemical Sensing,  
Chemical Delivery and Optical Stimulation  
 
by 
 
Ximiao Wen 
Doctor of Philosophy in Mechanical Engineering 
University of California, Los Angeles, 2018 
Professor Pei-Yu Chiou, Chair 
 
 Implantable neural probes are one of the most important technologies for 
neuroscientists to detect and stimulate neural activities inside the brain to advance the 
understanding of brain function and behavior, especially in the deep brain regions where 
other non-invasive approaches cannot reach. With the development of 
microelectromechanical systems (MEMS) in the past few decades, a great amount of 
efforts has been made to improve the neural probes to provide reliable and versatile tools 
to enable neuroscience studies that otherwise impossible to conduct.  
 In this dissertation, I focused on three important objectives to improve the current 
neural probe platform: 1) to incorporate optical stimulation capability on top of the current 
silicon-based microelectrode arrays (MEAs) with electrochemical sensing function for 
optogenetics applications; 2) to integrate microfluidic channels with the current silicon 
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platform for chemical deliveries; and 3) to develop a soft neural probe to reduce the brain 
damage and foreign body response. All the probes developed in this work are capable of 
deep brain implantation (>5 mm) and equipped with various electrochemical biosensors to 
study neural activities in deep brain regions.  
 For the first objective, an ultra-thin silicon nitride waveguide was integrated on top 
of the silicon probe using grating couplers to couple light in and out of the waveguide. 
PECVD silicon nitride film was optimized to reduce the waveguide propagation loss to ~ 
3dB/cm at 450 nm wavelength. The probe is capable of delivering ~40 μW light power to 
the probe tip with ~2 mW input light power from a 3 μm polarization maintaining optical 
fiber coupled with a pigtailed laser diode. The average light intensity is ~200 mW/mm2 
which is sufficient for Channelrhodopsin-2 excitation. Using this probe, we have detected 
optically-evoked glutamate release in the rat nucleus accumbens several weeks after 
injection of channelrhodopsin-expressing AAV into the above region.  
 For the second objective, PDMS microfluidic channels were transferred to the front 
and backside of the current Si probes using a novel PDMS thin-film transfer process. With 
this process, microfluidic channels can be easily bonded to Si probes as an add-on module 
to provide a simple solution to integrate chemical delivery functions into existing silicon-
based probes, providing another level of control of the brain activities. Local injection of 
drug solution with nanoliter precision can be controlled by the pumping pressure and 
duration. The system was validated in vivo by local glucose injection through the fluidic 
channel and detection by biosensors in rat striatum.  
 For the third objective, a multifunctional neural probe with Ultra-Large Tunable 
Stiffness (ULTS) was developed for chemical sensing, delivery and deep brain 
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implantation, whose stiffness can be tuned by 5 orders of magnitude before and after brain 
implantation. ULTS probe is stiff enough to penetrate 2 cm deep into a gel with similar 
mechanical properties as the brain tissue and becomes soft and flexible within few minutes 
to minimize brain damage due to the brain movements in all directions. With appropriate 
coatings, the electrodes on ULTS were converted into different biosensors which exhibits 
similar sensing performance as previous Si probes. The integration of microfluidic 
channels permits delivery of chemicals in the local vicinity of the sensing sites. Acute 
stimulation and sensing experiments were conducted in rats, in which potassium induced 
glutamate release was recorded demonstrating the capability of in vivo application. The 
chronic immune response was compared between ULTS and silicon probes with similar 
geometry, which shows a reduced immune response indicated by the lower astrocytes 
density around ULTS.  
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Introduction 
 
Brain is the most vital component of the human body, however it is least understood 
and its disorders are the most difficult to treat due to the extreme complexity[1]. Neurologic 
disorders accounts for 3% of total global burden of disease measured in disability-adjusted 
life years, such as Alzheimer’s disease, Parkinson’s disease, and epilepsy[2]. Therefore, it 
is of the utmost importance to understand the brain so that we can find treatments to brain 
diseases and create tools to enhance brain functions.  
Neural signal propagations are composed of conduction (electrical signal propagates 
within neurons) and neurotransmission (movement of chemicals across neurons) (Figure 
1.1). Various technologies have been developed to monitor the signal propagation and can 
be categorized into two major types, optical-based and electrical-based. Optical 
imaging[3]–[5] provides high spatial-resolution and fair temporal resolution detection over 
a large area, however its application is often limited to the cortex region due to the short 
optical transmittance in brain (~1 mm) and the bulky optical system prevents the 
implantation without severe brain damages. On the other hand, electrical-based system[6]–
[8] for detection of electrical and chemical signals is less invasive, which is an ideal tool 
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to monitor brain activities in deep brain regions. In addition, stimulation approaches 
including  optogenetics[9], chemical deliveries[10] and electrical stimulation[11] are 
commonly used to manipulate brain activities for scientific studies as well as disease 
treatment. Therefore, an implantable miniaturized platform with electrodes and other 
stimulation modalities is needed to facilitate the understanding of brain functions in deep 
brain regions.  
 
1.1 Electrochemical Biosensors 
Signal propagation between neurons is accomplished by the movement of 
neurotransmitters across the synapse, where they are released by the pre-synaptic neuron 
and activate post-synaptic receptors. To date, over 100 types of neurotransmitters have 
been identified, which could influence the function of neurons through various mechanisms 
and control the electrical excitability of the post-synaptic neuron in two ways: excitatory 
Figure 1.1 Neural signal propagation within and across neurons 
(http://www.rhsmpsychology.com/Handouts/synapse.htm) 
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or inhibitory. Neurotransmitters play a significant role in modulating brain activities. 
Imbalance of neurotransmitters could lead to many neurological and psychiatric disorders 
including Alzheimer’s disease, Huntington disease and Parkinson’s disease[12]–[16]. 
Therefore, it is extremely important to monitor different neurotransmitters to understand 
both normal and abnormal brain activities.  
Various technologies have been developed to detect neurotransmitters in deep brain. 
Microdialysis, as one of the most established methods, requires the insertion of a small 
catheter (microdialysis probe) into the brain. The microdialysis probe is composed of a 
liquid channel that is encapsulated by a semipermeable membrane, where small solutes can 
diffuse through and removed for downstream analysis (Figure 1.2)[17].  However, such 
approach suffers from low temporal (5-10 mins) and spatial (~mm) resolution, making it 
inapplicable for sophisticated behavioral studies[18]. Electrochemical sensing methods 
have been developed for neurotransmitters detection that provides millisecond-range 
Figure 1.2 Schematic illustration of a microdialysis probe (“Microdialysis,” Wikipedia) 
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responses and micrometer-range resolution[12], such as fast scan cyclic voltammetry 
(FSCV)[19] and constant potential amperometry (CPA). However, these approaches face 
difficulties of detecting a limited number of neurotransmitters and inability to selectively 
sense the neurotransmitter of interest without interference from other molecules with the 
similar redox potentials [20]. As the major excitatory neurotransmitter, glutamate (Glut) is 
non-electroactive which cannot be measured using above approaches.  
On the other hand, as demonstrated in Monbouquette lab and others[7], [8], [21], [22], 
non-electroactive species, such as glutamate and glucose, in biological tissue can be 
detected by coating the surface of electrodes with appropriate enzymes with near real-time 
response (~1 s) and micrometer scale spatial resolution. Oxidases are often used to 
selectively catalyze the formation of 
H2O2, which can be detected by 
electrooxidation to generate 
amperometric signals. Other polymers 
are coated to reject interferents utilizing 
mechanisms of size-based exclusion and 
charged-based repulsion to achieve 
selective detections. In this thesis, 
electrochemical sensing of 
neurotransmitters and glucose is used to validate the in vivo functionality of each platform.  
 
Figure 1.3 Schematic of glutamate sensors 
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1.2 Optogenetics 
Optogenetics[9] is evolving rapidly due to its importance that could reveal 
questions no other method could. Optogenetics enables light control of neurons which have 
been genetically modified to be sensitive to light. The function is realized by making 
specific cells express microbial opsins, which is a kind of light-activable transmembrane 
proteins. Depending on the type of opsin, the neurons can be both activated and inhibited 
using light at different wavelength. Figure 1.4 shows the most used opsins to depolarize 
and hyperpolarize the neurons[23]. Channelrhodopsin2 (Chr2) is commonly used to 
activate neurons with blue color (473nm) illumination. Halorhodopsin (Halo) and 
archaerhodopsin (Arch) are instead used to inhibit neurons with yellow color (570nm) and 
green color (520nm) illumination respectively. With this technology, people can target and 
control precisely defined events even in freely moving mammals[9].  
 
 
1.3 In vivo fluidic delivery 
Delivery of fluid into certain brain region is another important tool in neuroscience 
studies to help understand complex neural circuits, neurochemical interactions and help 
Figure 1.4 Schematic representation of microbial opsin used in optogenetics [23] 
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find treatments to brain diseases such as Parkinson’s disease and brain tumors[24]. In vivo 
neuropharmacology is the study of how drugs affect brain functions and behaviors, which 
requires drug delivery directly into certain brain region, providing faster response, higher 
spatial resolution and not being blocked by blood-brain barriers (BBB) compared to other 
routes of administration such as oral and intravenous administration. In addition to 
traditional pharmacological agents, there is an increasing demand for delivery of other 
fluidic agents, such as gene therapy vectors[25] and antibody treatments for chronic 
diseases[26]. Moreover, fluidic delivery can activate or inhibit neural activities directly 
through chemical/neurotransmitter delivery or combined with other technologies such as 
optogenetics[9], [10] and chemogenetics[27], [28]. For example, chemicals such as 
pilocarpine hydrochloride and tetrodotoxin were infused locally into a mouse brain to 
increase and decrease the neural activities at CA1 in hippocampus[29]. For optogenetics 
applications, viral vectors need to be designed and injected into the targeted brain region 
to modify neurons to be sensitive to light. Chemogenetics (Fig. 1.5), similar to optogenetics, 
uses chemically engineered molecules, such as designer receptor exclusively activated by 
designer drugs (DREADD), and small molecules ligands, like clozapine N-oxide (CNO) 
instead of light-sensitive channels and light to manipulate specific brain circuits and 
populations, which requires fluidic injection of both viral vectors and ligands. Although 
chemogenetics has inferior temporal resolution compared to optogenetics, it is better 
performed to influence larger brain regions and easier to implement.  
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Current in vivo chemical delivery relies on decades-old use of metal cannulas[27] or 
microdialysis[30], whose scales are on the order of a few hundred micrometers (Figure 
1.6). The large dimension leads to poor spatial precision to study brain microcircuits and 
cause significant brain damages. Therefore, people are pursuing innovative technologies 
with better spatiotemporal resolution, minimized tissue damage and integration with other 
tools.  
 
Figure 1.5 Optogenetics vs Chemogenetics 
(https://www.the-scientist.com/?articles.view/articleNo/44321/title/Remote-Mind-Control) 
Figure 1.6 Conventional cannulation system 
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1.4 Development of Implantable Neural Probes for Neuroscience Study 
Electrode-based implantable device was first made from insulated microwires in 1950s 
to record electrical signals from single neurons[31], which allowed neurophysiologists to 
study the activity of individual neuron in awake, free-moving animals. Since then, various 
technologies have been developed to improve the system, however the concept remains 
unchanged in the last few decades[32]. A tetrode (Figure 1.5) with four microwires is 
capable of detecting and separate individual neurons within a 50 μm radius, which contains 
~100 neurons, using clustering methods. And neurons within the radius of 140 μm, which 
contains ~1,000 neurons, could also be detected without separation[33]. Microwire based 
devices are widely used and inexpensive. However, microwires have limited number of 
electrodes, which are all located at the tip, preventing the detection along the microwires 
simultaneously.  
 
With the advancement of microfabrication technology, recording electrodes can be 
fabricated on silicon substrates with micron to nanometer scale precision. Since the first 
Figure 1.7 Schematic of electrophysiology recording from a tetrode 
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development of planar Si probes by Wise et al.[34] from University of Michigan, efforts 
have been made to increase the number of electrode sites, minimize the device dimension, 
integrate with integrated circuits (ICs) and even create 3D probe arrays. These probes with 
planar Si structures are commonly known as Michigan probes or Michigan arrays. In a very 
recent work, a silicon probe with 960 sensing electrodes and fully integrated CMOS chip 
has been developed, which can detect more than 700 isolated single neurons 
simultaneously[35]. With 130-nm CMOS fabrication process, nearly 1,000 electrodes are 
placed on a single, 10-mm long, straight shank with 70 × 20-μm cross-section with multiple 
layers of wires connecting out. Recorded signals are processed, multiplexed and digitized 
directly by the IC for read-out (Figure 1.6). Probes with planar structures have a limited 
recording volume within 50 μm from the probe shank. Hence a three-dimensional probe 
arrays is needed to achieve neuron recordings from a larger volume, which is typically 
fabricated by stacking 2D planar probe arrays[6], [36]–[38]. The commonly used silicon-
based microelectrodes arrays (MEAs) for electrochemical sensing also has the planar 
structure fabricated by microfabrication process to have precisely patterned sensing 
electrodes to achieve biosensing with high spatial resolution[7], [39].  
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 In addition to the efforts of improving Si probes in terms of the electrodes density 
to record more and more neurons, another major direction in developing implantable neural 
probes is to incorporate more functions together for more complex experimental studies. 
As introduced in previous sections, the integration with optogenetics and chemical delivery 
functions would help answer questions that otherwise impossible.  
 The most straightforward approach for simultaneous electrical recording paired 
with optogenetics and/or chemical delivery is done by inserting multiple implants, such as 
a tetrode, an optical fiber and a metal cannula. However, the drawbacks are excessive 
wound size and poor alignment precision among these devices. Therefore, a compact 
integrated multifunctional system is needed to minimize brain damage caused by the 
implants and to achieve highly localized sensing and stimulation.  
To date, there are two major approaches to make integrated light stimulation neural 
probes: (1) light delivery to the probe tip from outside through optical waveguide [40]–[43] 
Figure 1.8 Advanced planar silicon probes. (a) Silicon probe with ultra-high density of electrodes[34], 
(b) Multi-shank probes and (c) 3D probe arrays[37] 
a b 
c 
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and (2) integrate light source (LEDs) directly on the probe [44]–[46] (Figure 1.9). Each 
approach has its own advantages and drawbacks. Waveguide approach uses external light 
source, which eliminates the heat production inside the brain, while it usually has relative 
large power loss especially at the waveguide input end, and such device is tethered with 
optical fiber which would restrict the movement of animals. μLEDs put at the probe tip 
could provide higher light power, and the all electrical system could be powered wirelessly. 
However, such devices are complicated to fabricate and will generate excessive heat inside 
brain especially for applications required high-power and long-duration illuminations[47].  
 
The integration of microfluidic channel with Si neural probes is developed through 
surface micromachining[48]–[52] and bulk micromachining methods[29], [53]–[58] 
(Figure 1.10)[24]. In the case of surface micromachining, microfluidic channel is formed 
by first deposit and pattern a sacrificial layer (e.g. photoresist and SiO2), followed by the 
coverage of another material (e.g. silicon nitride, silicon oxide, metals and polymers) to 
A B 
Figure 1.9 Reperesentative neural probe with optial stimulation based on (A) waveguide [40] and (B) 
on probe μLEDs[44]. 
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form the top of the liquid channel. The channel is finished by removing the sacrificial 
material. In the case of bulk micromachining, microchannel is formed by the etching of 
bulk Si substrate followed by isotropic deposition or bonding of another layer to seal the 
channel.  
 
 Silicon neural probes are widely used due to the mature fabrication technologies 
from MEMS and CMOS processes. Such devices are great tools for acute and short-term 
applications, however, electrical recordings with increasing noise levels, decreasing signal 
amplitude and loss of detected neurons are often observed[59]–[61]. It is believed that the 
mechanical mismatch and micromotion between rigid silicon (E = 130-170 GPa) and soft 
neural tissues (E = 0.1-6 kPa) could leads to neuron loss and scar formation near the 
implants due to neuroinflammation response[62]–[64]. Therefore, there is a major 
motivation to develop polymer-based soft and flexible neural probes that could prolong the 
lifetime of the implants and minimize foreign body reactions and brain damages. Two 
Figure 1.10 Representative fabrication processes of Si microfluidic neural probes [24] 
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major strategies are taken to match the mechanical properties of neural tissues. The first 
one is to use softer material such as Parylene C, polyimide, SU-8 and PDMS as probe 
substrate[65]–[69]. And the second approach is to use stiff material but with dimension 
close to cell size (1-10 μm) [70]–[73]. Cases with improved chronic performance have been 
reported using both approaches. Nguyen et al.[68] reported neural probes made from soft 
polymer (E = 12 MPa) and observed nearly complete attenuation of inflammatory response 
and absence of neuron loss around the implant at week 16. Zhou et al.[74] compared SU-
8-based ultrasmall meshed structure with polyimide probe (E = 2.5 GPa) and showed less 
inflammation and higher neuron populations.  
 
The two primary objectives for the work described in the thesis are (1) integrating 
optical stimulation and chemical delivery functions on silicon probes to increase the 
functionality of the current silicon MEAs for electrochemical sensing; and (2) developing 
a 
 
b 
Figure 1.11 Reduced inflammation response and brain damage 
with soft substrate mateiral [68] and minimized implant 
dimension [74]. 
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a completely new ultrasoft PDMS-based neural probes with new implantation strategy 
aiming to reduce neuroinflammation response and brain damage.  
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Silicon neural probes with integrated optical waveguide 
 
2.1 Introduction 
Neural probes enable monitoring of local brain activities in both electrical and 
chemical ways, which is one of the most important tools to study brain functions in deep 
brain regions. However, neuroscience study can be more effective by using stimulation 
modalities while monitoring neuronal response and animal behavior changes to identify 
the functionality of a brain circuit [75]. Among various stimulation modalities, 
optogenetics provides both activation and inhibition of neurons with high spatial and 
temporal resolution that makes it a unique tool in neuroscience studies.  
In the early stage of combined optogenetics and electrical recording, commercially 
available components such as microwires, silicon neural probes and optical fibers were 
manually aligned and glued[76], [77]. The components are readily available to enable such 
studies right away, however, the relative distance between each component would be hard 
to control. In addition, such tools would create large brain damages due to the bulky size 
of optical fibers (~200 μm).  
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MEMS technology can not only enable micron-scale patterning, but is also capable 
of forming active (LEDs) and passive (waveguides) optical components by depositing and 
patterning layers of films or transferring from another substrate[44], [45], [78]. LED 
integrated neural probes provide advantages including high scalability and wireless 
capability, however, also have limitations including heat generation inside the brain, 
crosstalk between the driving circuits for the LEDs and electrical recordings, limited 
wavelength selection and incompatible fabrication processes. On the other hand, optical 
waveguides can be integrated monolithically using standard MEMS fabrication, without 
heating effects since the light source is out of the probe[47], which make it more suitable 
for applications with high power and long duration stimulations. Several silicon neural 
probes with optical waveguides have been demonstrated for electrophysiology 
recording[40], [79], however, combining optogenetics with electrochemical sensing using 
integrated silicon probes have not been demonstrated.  
We designed and fabricated silicon-based probes with integrated PECVD SixNy 
waveguides and grating couplers to deliver light from a single mode fiber to the probe tip. 
Light is emitted from the center of a sensing electrode perpendicular to the probe surface, 
enabling highly localized optical stimulation to neurons just above the sensing electrode. 
The PECVD SixNy waveguide was optimized to have low absorption to blue light (450 nm), 
and capable of deliver ~40 μW of light to the tip with 2 mW input light power from an 
optical fiber. We validated the device by detecting optically-evoked glutamate release in 
anesthetized rats’ nucleus accumbens several weeks after injection of channelrhodopsin-
expressing AAV into the above regions.  
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2.2 Design 
The waveguide integrated neural probe is based on the silicon-based MEAs for 
biosensing developed by Monbouquette lab[7], [39]. The probe thickness is defined by the 
thickness of the 4” silicon wafer,150 μm, which is smallest thickness that can be handled 
without cracking. The probe shank is 9mm long with a tapered width from ~400μm at the 
probe base down to 144μm at the probe tip. The probe consists of two Pt electrodes and a 
light stimulation site. The electrodes are designed to have the same surface area as in a 
prior work to satisfy the electrochemical sensitivity requirement[21]. Silicon nitride was 
chosen as the waveguide material due to its relatively large refractive index (~2) so that 
light can be better confined inside the core for denser integration. We deposited 200nm 
thin silicon nitride to avoid excess stress issue and reduce the deposition time. The 
waveguide is slightly tapered with width from 50 μm at the input port to 20 μm at the output 
port. Due to the extremely thin waveguide structure, butt-coupling method would have 
significantly large coupling loss, which is not applicable in our device. Instead, we decided 
to use grating couplers (GCs) for both input and output coupling, which could give much 
higher coupling efficiency in theory (Figure 2.1). 
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Grating couplers are designed using 2D Finite-Difference Time-Domain (FDTD) 
approach (RSOFT) to couple 450 nm wavelength blue light into the waveguide with an 
input coupling angle of 10º and a vertical output coupling. The GCs were finalized with 
the following parameters: 
input GCs: grating period λ = 300 nm, etch depth d = 100 nm, duty cycle η = 50%  
output GCs: grating period λ = 270 nm, etch depth d = 100 nm, duty cycle η = 50%   
which led to an input coupling efficiency of 13%, and output coupling efficiency of 50%.  
 
Figure 2.1 Schematics of the waveguide integrated silicon neural probe. (a) 3D schematics of the overall 
probe design. (b) Probe tip showing 2 electrodes and 1 light stimulation site.  
a b 
Optical fiber 
Figure 2.2 FDTD Simulation of input grating couplers 
Electrode 
Output GC 
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2.2 Fabrication process 
The fabrication process is summarized below (Figure 2.3). We first grew a 2 μm 
thermal oxide film on a 150μm-thick Si wafer as the bottom cladding, which was 
sufficiently thick to prevent leakage loss towards the silicon substrate[80]. A 200nm silicon 
nitride was deposited by PECVD by optimized NH3/SiH4 ratio of 9:1 to minimize the 
waveguide loss. The grating couplers and the waveguide were patterned by e-beam 
lithography and photolithography processes, and etched by RIE (Figure 2.4a). Finally, a 
1μm PECVD silicon dioxide film was deposited as the top cladding. Electrodes and 
interconnections (Cr/Pt 10nm/100nm) were fabricated on top of the cladding oxide layer 
by lift-off process. Another layer of silicon dioxide was deposited on top of the electrodes 
as an insulation layer, and the electrodes were opened by RIE etching. The probes were 
released from the silicon wafer using deep-RIE process for assembly and testing (Figure 
2.4b). 
 
(a) (b) 
(c) (d) 
Si SiO2 SiN Pt 
Figure 2.3 Process flow. (a) Deposition of 2 μm SiO2 and 200 nm SixNy using thermal oxidation and 
PECVD. (b) Pattern SixNy grating couplers and waveguides using e-beam lithography and contact 
lithography followed by RIE etching and deposition of top cladding layer. (c) Pattern metal layer using 
lift-off process, followed by deposition of insulating SiO2 layer. (d) Release probes from the substrate 
using DRIE process.  
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2.3 Optimization of PECVD SixNy film for reduced blue light absorption 
Since the most used opsin, Channelrhodopsin-2, is stimulated efficiently in the blue 
light range, with the peak absorption at 480 nm [81], the optical waveguide should have 
good performance in this range. However, it is very challenging since the light absorption 
typically increases at smaller wavelength (blue/UV). LPCVD stoichiometric Si3N4 film has 
been demonstrated to have low absorption in visible light range [80], [82], however, 
exhibited huge waveguide propagation loss in our trials, which might be due to the poor 
stoichiometry. Instead, PECVD SixNy provides higher flexibility in tuning the material 
properties by changing the gas ratio between NH3 and SiH4 and the plasma frequency. 
Increasing the flow rate of NH3 relative to SiH4 led to a decrease in the refractive index of 
the nitride film (Figure 2.5), as an indicator of reduced absorption coefficient in visible 
light range. As demonstrated in reference [83], the waveguide loss was minimized when 
the refractive index is less than 1.90 at 532 nm wavelength, which corresponds to gas ratio 
Figure 2.4 Fabricated structures. (a) SEM of a patterned grating coupler with 100nm etch depth and 
360nm period. (b) Released probes on a 4” silicon wafer.  
 21 
 
of NH3/SiH4 > 2 deposited by STS-PECVD at 380kHz plasma frequency. Gas ratio of 9:1 
was used to fabricate the waveguide on the probe, which has a refractive index of 1.867 at 
532 nm and 1.882 at 450nm.  
 
2.4 Results 
After releasing, a pigtailed laser diode (Wavespectrum Laser Group Limited) 
connecting to a polarization-maintaining fiber (PM-S405-XP, Thorlabs) was aligned to the 
input grating coupler, while the output power was collected by a 200 μm multimode fiber 
and measured by a photodetector (Figure 2.6). The waveguide loss was measured by a 
direct cut-back method, and yielded a propagation loss of ~ 3dB/cm. The maximum output 
power measured at the output grating coupler was ~40 μW with an input light power of 2 
mW, which yielded a total light delivery efficiency of 2%. The loss consisted of three major 
components, (1) input grating coupler (~8% efficiency, 11dB loss), (2) waveguide loss 
(~50%, 3dB loss), and (3) output grating coupler (50%, 3dB loss). The mismatch between 
the simulated and the measured input coupling efficiency could come from the errors in 
the film thickness deposited in each step and the etch depth of the grating couplers. It is 
Figure 2.5 Refractive index (λ=532 nm) decreases as the ratio between NH3 and SiH4 increases. 
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generally accepted that the light intensity threshold for stimulating Channelrhodopsin-2 is 
~1 mW/mm2, and several experiments have reported intensity less than 0.1 mW/mm2 
would be sufficient for stimulation. In our case, the dimension of the output grating coupler 
was 20 × 20 μm, while most of the light was emitted within 10 μm along the light 
propagation direction. Therefore, the light intensity above the GC can be calculated as 
40𝜇𝑊/(20𝜇𝑚 × 10𝜇𝑚) = 200 𝑚𝑊/𝑚𝑚ଶ, which is sufficient to stimulate the neurons 
sitting right above the GCs.  
 
Figure 2.6 Optical setup for optical fiber alignment and light power measurement. (a) Schematics of the 
optical setup. (b) Light coupling into the waveguide after aligning the optical fiber to the input grating 
coupler. (c) Light emitting from the GC at the center of a sensing electrode. Most of the light was emitted 
within first 10 μm length along the light propagation direction.  
a b 
40μm 
c 
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 To fix the position of the optical fiber on the probe, a transparent epoxy (E-30CL, 
Loctite) was used for initial fixation of the probe tip. The coupling angle in epoxy is 
different than that in air, due to the higher refractive index of ~1.5, and can be calculated 
by Snell’s law (Figure 2.7).  
𝑛଴ sin 𝜃଴ = 𝑛ଵ sin 𝜃ଵ , 𝑛଴ sin 𝜃଴ = 𝑛ଶ sin 𝜃ଶ  
⇒  𝑛ଶ sin 𝜃ଶ = 𝑛ଵ sin 𝜃ଵ 
Therefore, the angle of the optical fiber should be changed to 6.65º for an incident angle of 
10º in air.  
 Before aligning the optical fiber, the probe was mounted on a customized holder, 
so that more epoxy can be contained to increase the robustness of the package. After 
aligning the optical fiber to the GC, epoxy was used to pre-fix the fiber tip to the GC. To 
avoid fiber movement due to the epoxy shrinkage during the curing process, minimum 
volume of epoxy should be used and was done by dip coating the fiber into a drop of epoxy 
and then aligning to the GC. After epoxy cured, large volume of dental cement was applied 
to form a more stable packaging (Figure 2.8).  
 
n1 = 1 
n0 = 1.46 n0 = 1.46 
n2 = 1.50 
θ0 
θ1 
θ0 
θ2 
Figure 2.7 Alignment of optical fiber to GCs (a) with and (b) without epoxy. 
a b 
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The vertical illumination property was confirmed by immerse the probe tip in a dye 
solution. As shown in Figure 2.9, light was emitted almost vertically from the probe 
surface, with an angle of ~3º emitting backwards from the probe tip, which came from the 
fabrication error in the film thickness and GC etching depth. The light emitted from GCs 
has a small beam divergence angle, which potentially enables deeper penetration into the 
tissue.  
 
1cm 
Figure 2.8 Image of a packaged probe with light delivery to the probe tip 
100μm 100μm 
a b 
Figure 2.9 Light illumination pattern taken in a dye solution. (a) Front view. (b) Side view. 
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Channelrhodopsin-expressing AAV was injected to mPFC region of rats and waited 
for several weeks for the expression of ChR2 at nucleus accumbens (NAc). During the 
surgery, the probe was inserted to the NAc. Light power of 29μW was used for stimulation, 
which was calibrated before the experiment. The stimulation was conducted at 120Hz with 
a duration of 2s. Figure 2.10 shows the result of detected light-induced glutamate release. 
The light stimulation site was in the center of the channel 1 sensor. The black line 
represents the detected glutamate release to light stimulation of neurons with ChR2 
expression. To determine the level of light artifact, the probe was then implanted to the 
contralateral NAc, where neurons do not have ChR2 expression. Light stimulation was 
performed in the contralateral NAc using the same parameters, and resulted in a much 
lower signal level, and a sharp drop upon the end of the stimulation (Gray line). Subtracting 
the two lines, we got an artifact free glutamate sensing curve with a peak concentration of 
40μM, with a gradual glutamate decay to the baseline level, representing the glutamate 
uptake by surrounding neurons. It should be noted that Ch 2 did not show obvious 
glutamate level change other than noise, which may come from the LED controller, 
indicating the light stimulation was highly localized and did not affect the neurons near the 
other electrode 100 μm away. 
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2.5 Discussion 
Optogenetics is the most attractive technology to manipulate neural activities with 
extremely high spatial and temporal resolutions, which offers unparalleled advantages as 
compared with conventional electrical stimulation. At the same time, monitoring of 
chemical signals, such as neurotransmitters, provides invaluable insights about how 
neurons communicate with each other. The combination of these two technologies (closed-
loop optogenetics) would enable enormous researches to dissect neural circuits and cellular 
signaling and advance understandings of not only normal, but also many abnormal 
behaviors apparent in neurological and psychiatric disorders. However, a miniaturized 
neural probe with integrated functions of optical stimulation and electrochemical sensing 
has not been demonstrated and validated in vivo.  
Figure 2.10 In vivo responses collected from the biosensor incorporated with waveguide. The darker line 
is the response collected in the NAc expressing channelrhodopsin (ChR2). The lighter line is the response 
collected in the contralateral NAc without ChR2. Injection site: mPFC. 
20μM 
W/ ChR2 
W/O ChR2 
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In this study, we developed a new proof-of-concept neural probe with integrated 
optical waveguide and electrochemical sensing electrodes. The initial in vivo validation 
experiments demonstrated promising results of light-induced glutamate release with light 
power of 29 μW. Although there were some artifacts superimposed on the real signals, we 
were able to subtract them out from the pure artifact signal detected from the contralateral 
brain region without the ChR2 expression to get a pure chemical signal.  
A localized directional illumination pattern from the center of the sensing electrode 
and perpendicular to the probe surface was realized by using grating couplers to make sure 
the stimulation zone is well matched to the recording zone. Since the light was emitted 
through the transparent window in the center of the electrode, no light was directly 
illuminated onto the electrode, which could possibly reduce the level of light-induced 
artifacts to be low enough to recover the real signal. However, grating couplers are very 
sensitive to fabrication errors, such as the thickness of the bottom oxide, refractive index 
of the waveguide material, the duty cycle of grating couplers and grating etch depth, which 
would affect the efficiency significantly. In the future, optimization could be done after the 
deposition of bottom oxide and silicon nitride layer so that the fabricated structure would 
be better matched to the simulation design.  
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Silicon neural probes with integrated microfluidic channel 
 
3.1 Introduction 
Neural probes are one of the most important tools in neuroscience studies that 
enable recording of neural activities (electrical[1], [38], [75] and chemical[7], [21], [39]) 
in deep brain regions with high temporal and spatial resolutions. At the same time, various 
stimulation modalities, such as electrical, optical and chemical, are commonly used to 
manipulate neural circuits and animal behaviors for various purposes, such as to identify 
the function of the specific neural circuits, to repair/restore sensory or motor function and 
to treat disease[10], [85], [86]. Among these stimulation modalities, chemical delivery is 
of great interest for both fundamental neuroscience research[85] and clinical medicine[10], 
[87]. Combining the chemical delivery with recording function enables simultaneous 
observation of neural activities in response to the chemical/drugs, which would help study 
complex nervous system[24] and assess the efficacy of new pharmaceutical drugs[29]. 
The most commonly used approach relies on implanting separate or assembled 
metal cannula and neural probes, which causes huge damage to the targeted brain region 
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due to the large footprint size. Moreover, the distance between the liquid channel and 
electrodes is hard to control, leading to poor experiment repeatability. Therefore, with the 
advances of MEMS technology, various silicon probes with integrated microfluidic 
channels (chemtrodes) have been developed using bulk or surface micromachining[24]. 
For bulk micromachining, the channel is formed by etching the silicon substrate and sealed 
by either deposition of isotropically grown materials such as PECVD oxide and nitride[56] 
or wafer bonding[29], [54]. For surface micromachining, the channel is formed by removal 
of sacrificial film deposited on top of the silicon substrate[52]. The silicon chemtrodes can 
be batch fabricated with high precision, however often involve complicated fabrication 
processes such as wafer bonding, polishing, deposition and etching of many films. The 
process to fabricate fluidic channels is often more complicated than the fabrication of 
electrodes. 
In this work, we developed a customized PDMS thin-film transfer process based 
on conventional soft lithography technology that enable easy microfluidic channel 
integration on conventional silicon probes. Thin PDMS channels can be easily transferred 
to existing neural probes as an add-on module that could enable highly localized chemical 
delivery immediately. The process can also be applied to wafer-level fabrication to 
integrate microfluidic channels to hundreds of probes in parallel. PDMS microfluidic 
channel with a total thickness of 15 μm, and a channel dimension of 10 × 20 μm (thickness 
× width) was fabricated that enables precise chemical delivery at flow rates ranging from 
0.25 to 1.75 μL/min with pumping pressure from 5 to 20 Psi. The proposed microfluidic 
neural probe was validated in rats with simultaneous chemical delivery and electrochemical 
sensing that proved the viability of the PDMS/Si hybrid chemtrode.  
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3.2 Design 
The microfluidic channel is designed to be integrated to the existing silicon-based 
probes[7], [21], [39], [88] to enable simultaneous chemical (e.g. neural transmitters) 
delivery and electrochemical sensing capabilities at the same time to provide a method to 
validate the in-vivo functionality of a specific biosensor as well as to study fundamental 
neuroscience. To demonstrate the capability of the fabrication process, microfluidic 
channels were added to both front and back side of the silicon probe, and the latter case 
was characterized and tested in vitro and in vivo.  
Microfluidic channel was first integrated with the optogenetics probe described in 
chapter 2 to achieve 3-in-1 multifunctional neural probes (Figure 3.1). The fluidic channel 
was transferred to the front side of the probe with liquid outlet 40 μm away from the top 
electrode. Due to the limited space on the front side of the probe, the fluidic channel was 
routed to an extension platform out of the probe for inlet connection. Two layers of PDMS 
thin-films were transferred, where the 10 μm-thick bottom layer was used to prevent 
leakage from the interface between the probe and outside platform. The top layer contained 
a 9 mm × 20 μm × 10 μm (length × width × height) channel and a 5 μm-thick cover.  
Microfluidic channel was also transferred to the backside of the traditional silicon-
based biosensors (Figure 3.2). Since there were plenty of room on the backside for inlet 
connection, one layer of PDMS thin-film with channel was transferred directly to the probe 
surface to form an enclosed channel, with the silicon probe itself as the channel bottom 
surface and PDMS as the cover. It also eliminated the need for the fabrication of the 
extension platform, which made the fabrication more straightforward. As suggested by 
Chen et al.[89], the fluid outlet with a diameter of 40 μm was placed on top of the PDMS 
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membrane instead of facing forward towards the probe tip to avoid channel occlusion 
during the probe insertion process. The liquid outlet was placed on the backside of the 
probe, right beneath the center point of the four electrodes. Same as the first design, the 
channel is 9 mm-long with a cross-sectional dimension of 20 × 10 μm.  
 
1mm 
100 μm 
(a) 
(b) 
Figure 3.1 Schematic diagrams of a optogenetics probe with integrated microfluidic channel on the front 
side of the probe. (a) Overview of the structure. (b) Enlarged view of the probe tip showing the 
electrodes, waveguide and liquid channel.  
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3.3 PDMS Thin-film Transfer Process 
A customized PDMS thin-film transfer process was developed based on previously 
reported process[90], with higher yield, efficiency and alignment accuracy. The process of 
fabricating the two-layer microfluidic channel on the front surface of silicon probe is 
illustrated in Figure 3.3 as an example. Instead of SU-8, silicon wafers were processed as 
molds due to the flat top surface even with multiple-layer structure, which is critical in the 
following pressing process. Masked by photoresist and silicon dioxide together, we were 
able to fabricate silicon molds with two etching depth, creating more complex structures 
with one molding/demolding process, such as creating isolated ultra-thin microfluidic 
channels with one transfer process. Otherwise, we would need to transfer a thin-film with 
a trench and then transfer a cover separately. Single-layer SU-8 mold tends to have ~1-2 
μm height different across the wafer, which is even worse for double-layer SU-8 mold. 
Using silicon molds, the chance of having large-area uniformly pressed film was 
Figure 3.2 Schematic diagrams of a silicon probe with integrated microfluidic channel on the backside. 
(a) Overview of the structure. (b) Enlarged view of the probe tip showing the electrodes and liquid 
channel. 
1mm 100μm 
(a) (b) 
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significantly increased. Silicon molds with even more etching depth are also possible to 
make by incorporating other materials as etching masks, such as silicon nitride. 
 
The detailed fabrication process is described below: 
1. The silicon molds were fabricated using the standard MEMS fabrication 
process with two photolithography, one RIE etching process to remove 
Figure 3.3 Process flow of the PDMS thin-film transfer process 
(a) 
(b) 
(c) 
(d) 
(e) 
(f) 
(g) 
(h) 
PR 
SiO
2
 
Si 
Glass 
PDMS1 
PDMS2 
Base layer Top layer 
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silicon dioxide and two DRIE process to create two etching depth into the 
silicon wafer (Figure 3.3a-c).  
2. After mold fabrication (Figure 3.3c), the molds were treated with trichloro-
Ĳ1H,1H,2H,2H-perfluorooctyl)silane (97%, SigmaAldrich, USA). This 
surface treatment was carried out in a vacuum chamber at a pressure of -30 
Psi for overnight. 3 μL of silane was added into the vacuum chamber, which 
is critical to achieve a relatively strong adhesion between PDMS and silicon 
molds.  
3. Next (Figure 3.3d), freshly made PDMS was poured into the mold and 
pressed by a silane coated glass at room temperature to unwanted thermal 
expansion in PDMS. PDMS was prepared by first mixing 10 g pre-polymer 
with 10 μL Pt catalyst (PLATINUM-
DIVINYLTETRAMETHYLDISILOXANE COMPLEX; 2% Pt in xylene; 
Gelest, Inc) and then mixing with 1 g of cross-linker. Pt catalyst was used 
to speed up the curing process at room temperature (~6 hours). Glass were 
coated with silane using the same procedure described above, however with 
much higher silane volume of 20 μL to lower the adhesion force between 
the PDMS thin-film and the glass. A PDMS buffer was placed on top of the 
silane treated glass and then covered by another regular glass. Then, a large 
pressure was applied to the glass to press the uncured PDMS out of the mold. 
The pressure can be applied using heavy weight (20 kg) or from a pressure 
source.  
4. After PDMS curing (~6 hours in room temperature), the silane coated glass 
 35 
 
was peeled off. The PDMS thin-film was left inside the mold due to the 
stronger adhesion force between the PDMS and silicon molds compared to 
the force between PDMS and the silane coated glass (Figure 3.3e).  
5. Another layer of PDMS (same as described above) was poured on top of 
the PDMS thin-film and covered by a silane-coated glass separated by a 
spacer (~3 mm). After PDMS curing (~6 hours), the PDMS thin-film can be 
detached from the mold by peeling the top glass slide (Figure 3.3f, g). The 
second PDMS layer was needed to achieve better bonding results, while the 
glass backing was used to make sure that there would be no deformation of 
the PDMS layer to achieve highly precise alignment (<5 μm). 
6. The PDMS film was then bonded to the substrate (silicon, oxide or PDMS) 
using oxygen plasma (500mT, 80W, 30s; Technics MICRO-RIE, SERIES 
800). The alignment was performed using a Quintel mask aligner.  
7. After alignment and bonding, the device was baked in oven at ~65 ºC for >1 
hour to achieve better bonding strength before peeling off the second PDMS 
layer. The thick PDMS layer can be removed easily, leaving the thin-film 
bonded to the substrate. The relatively poor adhesion between these two 
PDMS layer is presumably due to the silane residue on the PDMS thin-film 
during the pressing process by the silane coated glass. When lower adhesion 
is required, the PDMS thin-film can be coated with silane with very low 
volume and time (e.g. 1 μL, 10min). It should be noted that the ultimate 
bonding strength (>60 Psi) is usually achieved after 6 hours baking in oven 
at 65 ºC. 
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Figure 3.4 shows the transferred microfluidic channel on the optogenetics silicon 
probe. The channel outlet was aligned right next to the electrode showing the capability of 
highly co-localized electrochemical sensing, optical stimulation and chemical deliveries.  
 
 Figure 3.5 shows the transferred microfluidic channel on the backside of a 
conventional silicon probe with the liquid outlet facing perpendicular to probe surface 
instead of pointing to the probe tip, which would prevent channel clogging issue during the 
implantation process.  
Figure 3.4 SEM of PDMS microfluidic channel transferred to the optogenetics probe 
 37 
 
 
3.4 In vitro characterization 
The injection behavior of the microfluidic channel on the backside of silicon probes 
was tested in a brain phantom (0.6% agarose gel). ULTS probe was connected to a 
microfluidic tubing with preloaded liquid, which was connected to a constant pressure 
source. The probe was then implanted into a brain phantom to simulate the brain 
environment. Liquid started flowing out as soon as we turned on the pressure source, and 
the time duration for injecting all the liquid preloaded in the tubing was recorded. The flow 
rate was determined by the ratio between the preloaded volume and pumping duration. 
Flow rates at different pumping pressure (5-20 Psi) were tested for 3 times to determine 
the system repeatability. 
The chemical delivery function was evaluated by injecting aqueous solution of red 
colored dye into brain phantoms with a pressure source (Figure 3.6a). The flow rate of the 
PDMS microfluidic channel was measured at various pumping pressures ranging from 5 
Psi to 20 Psi (Figure 3.6b), which demonstrates a linear relationship (R2 = 0.996) versus 
Outlet 
Figure 3.5 Microscope image of a microfluidic channel integrated on the backside of a silicon probe 
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the pumping pressure and high repeatability (n = 3). As suggested by Neeves et al.[52], 
backflow of infused solutions up the along the needle shaft would happen at flowrate higher 
than 1 μL/min, when the tissue was separated from the probe surface due to the large 
flowrate. It is also suggested that the backflow is correlated with the damage caused by the 
implant in terms of the size, insertion procedure. For a 30-ga needle, backflow was 
observed at a flowrate of 0.41 μL/min, while it was not observed until pumping at a much 
higher flowrate of 4.5 μL/min for a miniaturized neural probe with dimension of 100 × 100 
μm (width × thickness). Poor insertion procedure would create larger wound in the brain 
and increase the possibility of backflow. Therefore, it is critical to have minimal increase 
of probe dimension with additional microfluidic channel; find out the range of flowrate 
without backflow and minimize the brain damage during the probe implantation process.  
 
 
a b 
Figure 3.6 Fluidic injection in gel. (a) Optical image that demonstrates delivery of liquid (aqueous 
solution with red dye) into a brain phantom (0.6% agarose gel in water). (b) Flow rate of the 
microfluidic channel at different pumping pressures shows a linear relationship versus pumping 
pressure (R2 = 0.996) and high repeatability (n = 3). 
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3.4 In vitro test 
Next, we tested the integrated functions of electrochemical sensing and chemical 
delivery in an artificial cerebrospinal (aCSF)-brain phantom (0.6% w/v agarose in aCSF), 
by injection and detection of the same chemicals, glucose (800 μM). Local injections of 
the chemicals were immediately captured by biosensors (Figure 3.7). The current level 
starts decreasing when the injection ends based on pure diffusion. Fluid was injected at 20 
Psi with 2 pumping duration, 2s and 0.2s, and repeated for three times. Under the same 
injection condition, the detected signal had almost identical pattern demonstrating the 
repeatability of the fluidic channel.  
  
 
 
Figure 3.7 In vitro testing of 800μM glucose injection and detection in 0.6% agarose gel. The slow 
decrease in the glucose concentration is based on pure diffusion. Pumping pressure, 20Psi.  
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3.5 In vivo test 
We also validated the chemtrode with glucose sensors in rat striatum. The 
integrated probe eliminates the need of inserting separate reference electrode and needle, 
hence reduces the brain damage and improve the alignment precision of the sensors and 
fluidic outlet. For in vivo tests, 4 mM glucose in aCSF solution was injected at 20 Psi with 
various injection duration. We converted the current signal to glucose concentration based 
on a calibration curve tested before the in vivo experiment. In this experiment, glucose 
injection was captured by biosensors immediately, followed by a sharp decrease which was 
likely due to the glucose uptake (Figure 3.8). Increasing the glucose injection duration not 
only increased the rising time, which is the same as the injection duration, but also 
increased the peak concentration, meaning more glucose reached the sensing sites.  
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We repeated the same experiment, which showed similar trend. By increasing the 
pumping duration, the signal level increased first (0.2-0.8s), and reached plateau at duration 
longer than 1.2s. At the same time, we also noticed some variations of glucose signal in 
terms of both signal pattern and amplitude (Figure 3.9). First, the baseline glucose level 
was very low in the first experiment, while it was much higher in the second experiment, 
which may come from the variation in different animals, and surgery procedures. Second, 
there was a reduction of glucose level below the baseline level following the injection, 
which may be due to the over-absorption of glucose from surrounding neurons.  
0.5s 
1.0s 1.0s 
2.0s 2.0s 
4.0s 
4.0s 
0.5s 
Figure 3.8 In vivo glucose (4mM) injection and sensing. Injection pressure was kept at 20 Psi with various 
injection duration. The detected glucose concentration peak increases as the pumping duration increases, 
meaning more glucose reach the sensing sites. Current response was converted to concentration based on 
pre-calibration curve.  
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3.6 Discussion 
Chemical delivery is one of the most important tools in neuroscience with 
numerous applications such as stimulation and inhibition of neuron activities, modify 
neurons by delivery of virus for optogenetics and chemogenetics, treat diseases like tumor 
by delivery pharmaceutical drugs. The combination of chemical delivery with other 
modalities such as optogenetics and electrochemical sensing will dramatically increase the 
diversity and possibility of conducting different neural science studies, and answer 
questions that cannot be answered using individual function alone. However, the 
integration of multiple functions into a miniaturized neural probe is usually complicated, 
and requires completely different fabrication process.  
Figure 3.9 Second in vivo experiment with 4mM glucose injection and sensing. Green and blue curves 
represent signals from glucose sensor and a control electrode.  Pumping pressure, 20 Psi 
0.2s 
0.4s 
0.8s 1.2s 1.6s 2.0s 3.0s 4.0s 
control 
sensor 
100μM 
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In this work, we presented a novel approach to integrate microfluidic channels on 
off-the-shell neural probes using a novel PDMS thin-film transfer process. Microfluidic 
channels have been transferred to two types of neural probes: (1) the optogenetics neural 
probe describe in chapter 2 and (2) existing neural probe developed by Monbouquette lab, 
while the latter case was validated in rat striatum with glucose injection and sensing. The 
key innovations of this work are the simple and versatile fabrication approach that is 
capable of wafer-level process as well as on-demand integration onto individual probes. 
The neural probes with microfluidic channel on backside instead of frontside were tested 
in vitro and in vivo because of the simpler fabrication process as mentioned above. 
However, it can be solved by simply enlarge the area of the probe base to accommodate 
fluidic adapters without changing any process to achieve the close distance between liquid 
outlets and electrodes with transfer of only 1 layer of PDMS thin-film.  
We have noticed some variations of the detected signal with glucose injection in 
gel and in vivo. With dye injection experiment in gel, we observed the variation of the dye 
pattern at the probe tip and backflow at higher flowrate, which is highly related to the 
insertion procedure and the wound created by the probe. To minimize the tissue damage 
and backflow, the probe needs to be aligned in parallel with the insertion direction and the 
flowrate needs to be optimized.  
The current experiment of injection and detection of the same chemical can be used 
as an easy approach to validate the in vivo performance of novel biosensors. In 
neuroscience studies, other chemicals can be injected to manipulate neuron behaviors. For 
example, potassium can be injected to depolarize neurons and trigger neural transmitter 
release, which consumes glucose, the source of energy. Other chemicals are also proposed 
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to be injected to silence the optogenetics response of the modified neurons to quantify the 
light artifact level. In these experiments, the transient flow pattern is less important, since 
it could take several minutes for the chemical/drugs to diffuse and get into a larger volume 
of cells to show the effects.  
Although microfluidic channel with only one channel is demonstrated for chemical 
delivery, it can be easily scaled up with more liquid channels for chemical delivery at 
different location without increasing the dimension of the total thickness. Moreover, the 
microfluidic channel can also be converted to optical waveguide for optogenetics when 
filled with high refractive index material such as SU-8 and PDMS (GELEST OE-50).  
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PDMS Neural Probes with Ultra-large Tunable Stiffness 
 
4.1 Introduction 
Implantable neural probes are important technologies for neuroscientists to detect and 
stimulate neuronal activities inside the brain. These tools are also employed to stimulate 
neural networks as a clinical treatment, known as deep brain stimulation (DBS), to various 
diseases such as Parkinson’s disease, epilepsy, depression and obsessive compulsive 
disorder (OCD)[64], [85], [91]. When combined with in vivo neuropharmacology, 
microinjection of chemicals or virus, neural probes enable additional level of manipulation 
of neural activities, animal behaviors and treatment of neural diseases[10], [79]. Current 
approaches rely on implanting neural probes assembled with fluidic tubes for drug delivery, 
which causes huge damage to the targeted brain region due to their large footprint sizes. In 
the past few decades, with the development of microelectromechanical systems (MEMS), 
a great amount of efforts has been made to develop miniaturized multifunctional neural 
probes. Various silicon-based probes integrated with microfluidic channels have been 
developed [56], [92], [93]. However, the large mechanical mismatch between the rigid 
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probes (E~200 GPa) and the soft brain tissue (E~0.1-6 kPa) triggers long-term 
inflammatory responses that cause neuronal loss and scar formation around the implants. 
These rigid probes also result in extra brain damage due to brain motion[62]–[64], [94].  
In recent years, efforts have been put on developing flexible probes based on polymers 
such as polyimide, parylene-C and SU-8 to reduce chronic immune response[72], [73], 
[95], [96]. However, due to their weak mechanical stiffness, there is a major challenge to 
directly implant soft probes into brain tissues. To mitigate this issue, soft probes are either 
coated with stiffening polymer that can be dissolved after implantation, or made of polymer 
whose stiffness can be tuned before and after implantation[62], [96]–[98]. However, deep 
brain penetration is challenging for such probes due to the low Young’s modulus (~2 GPa) 
of polymers. Probes with large cross section area are needed to provide sufficient stiffness 
to prevent buckling during insertion[96], [97], [99]. Soft probes can also be attached with 
a stiff shuttle, such as a metal syringe and Si probes, that can be retracted after insertion[72], 
[73], [45]. The final location of the inserted probes, however, can be easily disturbed during 
shuttle retraction processes[100]. These approaches also require manual assembly 
processes, which makes them difficult to extend applications for fabricating multi-shank 
and 3D probe arrays. These insertion challenges together with other issues such as 
multifunction integration complexity and small footprint size requirement make the design 
and fabrication of flexible multifunctional probes for deep brain applications very difficult.  
This work presents a multifunctional flexible and stretchable neural probe whose 
stiffness can be tuned by 5 orders of magnitude before and after brain insertion for chemical 
sensing and chemical delivery deep within the brain. This neural probe with Ultra-Large 
Tunable Stiffness (ULTS) can penetrate 2 cm deep into a gel with similar mechanical 
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properties as brain tissues. For in-vivo testing, this probe can penetrate 5mm deep into the 
rat brain. Once implanted, the probe becomes soft and flexible within a few minutes. With 
miniaturized design (30 μm thickness) and soft substrate material (1 MPa), this flexible 
and stretchable probe can greatly minimize brain damage due to brain movements in all 
directions[68], [101]. Deposition of appropriate enzymes and exclusion polymers onto the 
platinum electrode sites on ULTS permits electrochemical detection of neurotransmitters 
from deep-lying brain structures, and the integration of a microfluidic channel allows 
delivery of drugs and other chemicals in the local vicinity of the sensing sites. This is the 
first demonstration of a self-implantable, flexible multifunctional probe that integrates 
chemical sensing and chemical delivery capability into a compact footprint size for deep 
brain applications.  
 
4.2 Design 
 The objective of making ultrasoft neural probes with large tunable stiffness and 
comparable sensing performance as silicon probes, we started our design from two 
fundamental elements: (1) to use PDMS as the substrate material due to its low Young’s 
modulus of around 1 MPa, high stretchability of ~600% and biocompatibility[24], [85], 
[102]; and (2) to integrate platinum as sensing electrodes which are required for high 
performance electrochemical sensing and can be directly compared with prior works 
demonstrated on rigid silicon probes[7], [21].  
Inspired by previous works done by John Roger’s group [103], [104], thin oxide 
film is flexible and making metal patterning easy and straightforward. Therefore, in the 
first design (Figure 4.1), we fabricated Pt wires and electrodes on top of a 1 μm-thin SiO2, 
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which was then covered by thicker PDMS film to provide temporary stiffening. However, 
after probe released in XeF2, oxide cracks are observed. The difference between our 
structure and other works are the substrate material, PDMS vs. Polyimide. Polyimide is a 
relatively soft material compared to Si, however it is only bendable, while PDMS is much 
softer and highly stretchable. Continuous thin oxide film is prone to be stretched together 
with the PDMS substrate to reach its fracture point (~2%)[105] and break into pieces. On 
the other hand, we also noticed that the small oxide pieces are hard to be broken further 
under stretching since most of the strain is experienced by the PDMS under the cracks.  
 
The finding gave us two inspirations: (1) isolate rigid and fragile components, such 
as oxide and metal, and leave most of the space with PDMS only; and (2) electrical 
interconnects need to be formed by intrinsically stretchable material to avoid cracking 
issues. Metal wires, such as gold and platinum are ductile to some extent, however starts 
Figure 4.1 Initial design of the PDMS-based probe. (a) Process flow. (b), (c) Oxide cracks after probe 
release.  
a 
b 
c 
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to crack with ~10% stretching[106], which is significantly smaller than the stretchability 
of PDMS despite the concern of poor adhesion between metal films and PDMS[102]. 
Devices with larger stretchability have been demonstrated by forming in-plane or out-of-
plane serpentine metal lines[107], [108], however inevitably increased the device 
dimension, which is undesired for implantable neural probes. Gallium (Ga), a liquid metal, 
is used to provide electrical connections to these electrodes on the flexible and stretchable 
probe without cracking and delamination issues. In principle, liquid metal can be stretched 
infinitely following the deformation of the substrate such as PDMS[109]. Ga is highly 
conductive with a resistivity of ~ 140 nΩ·m, close to that of platinum (106 nΩ·m), which 
is 6 orders of magnitude higher than that of conductive polymers. At the same time, it can 
be filled into microfluidic channels, which can be easily fabricated using the customized 
PDMS thin-film transfer process as described before. Another reason of choosing Ga is its 
near body temperature melting point (~30 ºC) and relatively high Young’s modulus at solid 
state (10 GPa), making it a promising material to temporarily stiffen the probe for brain 
penetration.  
With above mentioned considerations, the finalized design has a four-layer free 
standing structure that integrates Pt electrode, microfluidic channels and soft PDMS 
substrate (Figure 4.2). The purpose of each layer is described as follows: 1. electrodes 
formation: platinum electrodes are fabricated on thin and small silicon dioxide islands on 
a silicon substrate and transferred onto the probe for electrochemical sensing, which has 
the same exposed area (5656 μm2) as the silicon probes[7], [21]. 2. PDMS layer 1: ~5 μm-
thick PDMS thin-film physically connects the electrodes on the probe tip with the probe 
base with vias for electrical contacts and liquid outlet (radius = 15 μm), as well as bottom 
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passivation of electrical interconnects and drug delivery channel.  3. PDMS layer 2: PDMS 
thin-film with microfluidic channels for Ga interconnects and chemical delivery as well as 
top passivation. This layer has three microchannels with cross-section of 15 × 5 μm (w × 
t) and separated by 15 μm. The total thickness is ~10 μm. 4. PDMS layer 3: PDMS 
stiffening channel filled with Ga and frozen into solid state to provide strength for brain 
penetration. This layer is 15 μm thick with a 104 × 10 μm (w × t) microchannel. The probe 
is designed to be a 9 mm-long, 144 μm-wide and 30 μm-thick straight (non-taper) single 
shank structure. 
 
 
Utilizing the elastic property of PDMS, Ga in the stiffening channel can be filled 
with high pressure to increase the cross-section area by expanding the PDMS channel 
(Figure 4.2), which would further increase the probe stiffness. Therefore, there are two 
changing factors contribute to the ultra-large tunable stiffness: (1) phase change of Ga from 
solid state (E = 10 GPa) to liquid state (E = 0), and (2) shape change of the stiffening 
channel, where the bending stiffness is increased by the cube of the probe thickness. 
Figure 4.2 Schematics of the probe design. (a) Exploded view of the probe shows the four-layer structure 
of platinum electrodes and three layers of PDMS thin-films. (b) Final device with filled Ga 
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Therefore, we named our devices as neural probe with Ultra-Large Tunable Stiffness, 
ULTS.  
 
 
Therefore, to fully utilize the tunable stiffness range, the implantation concept 
involves the following key steps (Figure 4.4): (1) selective brain cooling with cold saline 
of targeted depth down to below 30 ºC, (2) implantation of ULTS probes in “stiff” and 
“expansion” state following typical implantation procedures, (3) brain temperature 
recovery after stop applying cold saline and ULTS probes turn into “soft” and “flat” state 
to further reduce the bending stiffness. 
 
a b 
Figure 4.3 Schematic diagram showing the stiffening channel inflation. (a) Flat channel without 
pressure. (b) Inflated channel with pressurized Ga  
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4.3 Fabrication Process 
The multifunctional ULTS probes were fabricated on Si wafers using conventional 
MEMS fabrication process for electrodes patterning and a customized PDMS thin-film 
transfer process to form the probe substrate and microchannels. Detailed steps involved in 
the fabrication of ULTS probes are illustrated in Figure 4.5, and the PDMS thin-film 
transfer process are illustrated in Figure 4.6, described in Chapter 3. The multifunctional 
single-shank ULTS probe has 1 drug delivery port and 2 electrochemical sensing sites. Key 
parameters of the probe are as follows: probe width, 144 μm; probe length, 9 mm; exposed 
electrodes area, 5656 μm2; thickness of three PDMS layers, 5 μm, 10 μm and 15 μm 
respectively; microchannel dimension of electrical interconnects and drug delivery, 15 × 5 
μm (width × height) and channel dimension of Ga stiffening, 104 μm × 10 μm (width × 
height). Key fabrication processes are summarized below: (i) Pt electrodes, soldering pads 
and SiO2 insulators were patterned on a silicon substrate, which serves as a sacrificial layer 
(Figure 4.5 a-e). (ii) Photoresist (AZ 4620, ~5 μm) was patterned on the processed 
Figure 4.4 Schematics of the implantation procedure. Tissue is cooled down from the surface by 
application of cold saline. White dashed line represents the temperature of the Ga melting point, 30 ºC, 
above which the probe remains stiff. 
37 ℃ 
0 ℃ 
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wafer to define the vias and probe shapes. PDMS was then applied and pressed to a thin-
film by a silane treated glass. Photoresists were removed in acetone with sonication to 
expose the vias. Oxide in the vias was then etched by RIE, with PDMS as the etching mask 
(Figure 4.5 f-h). (iii) A second PDMS thin-film with microfluidic channels and top 
passivation was transferred and bonded to the first PDMS layer via O2 plasma (80 W, 500 
mT, 30s) (Figure 4.5 i). (iv) A third PDMS stiffening channel was transferred and bonded 
via O2 plasma (Figure 4.5 j). (v) Liquid Ga was injected into interconnects and stiffening 
channels and frozen to solid state to maintain the shape and strength after XeF2 releasing 
process (Figure 4.5 k). (vi) The probes were released by the Si undercut using XeF2 in a 
pulse mode in which the etching chamber is repeatedly filled with XeF2 gas to 1500 mT 
and kept for 60 s, and then pumped out to 50 mT (Figure 4.5 l). It should be noted that 
XeF2 etching of Si is an exothermic reaction. The etching rate needs to be controlled to 
Figure 4.5 Fabrication process of ULTS probes with cross-section along the long axis of the probe: (a)-
(e) Pt electrodes and oxide patternnig on Si wafer. (f)-(h) Pattern first layer PDMS using “lift-off” 
process to creat vias. (i)-(j) Transfer of PDMS thin-films. (k) Fill in Ga. (l) Prob release in XeF2.  
Si wafer with 1μm oxide 
BOE pattern hole 
Pattern Cr/Pt/Cr 
Etch oxide 
Press 1st PDMS layer 
Etch oxide 
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Transfer 2nd PDMS layer 
Transfer 3nd PDMS layer 
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Release Probe 
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b 
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prevent excessive heat accumulation that could melt the solid Ga. The 2 cm-long single-
shank probes and 1 cm-long 4-shank probes are designed to demonstrate the mechanical 
properties of ULTS probes, which only have 2 layers of PDMS, (1) bottom passivation (10 
μm thick), and (2) stiffening channel (20 μm thick), without sensing electrodes, electrical 
interconnects and drug delivery channel. The spacing between shanks is 500 μm, which 
can be easily reduced.  
 
 After release, the probes remain straight and stiff (Figure 4.7 a) and ready for brain 
implantation. Melting the Ga at elevated temperature (> 30 ºC), the probe becomes soft and 
Figure 4.6 PDMS thin-film transfer process. (a)-(c) Si mold fabrication. (d) Press PDMS thin-film by a 
silane treated glass slide. (e) Remove glass and leave thin-film in mold. (f) Apply another layer of 
PDMS to (g) pick up the thin-film and for tranfer-bonding. (h) Remove the second PDMS layer leaving 
the thin-fim bonded to the substrate.  
a 
b 
c 
d 
e 
f 
g 
h 
PR 
SiO2 
Si 
PDMS1 
PDMS2 
2nd 3
rd 
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flexible (Figure 4.7 b). In the same way, four-shank probes are fabricated and stacked to 
form 3D probe arrays (Figure 4.7 c).  
 
4.3 Characterization of Probe Tunable Stiffness 
To investigate the tunable stiffness range, we first characterized the probe 
deformation with respect to different Ga filling pressures (Fig. 4.8). The maximum 
pressure injected was 60 Psi, which resulted in the largest deformation of ~67 μm. The 
channel was expanded close to a semicircle with radius of 52 μm at pumping pressure of 
30 Psi.  
200μm 
Electrodes 
Outlet 
0.5 mm 0.5 mm 
a b 
c 
Figure 4.7 Images of released probes: (a) Picture of an ULTS probe in the stiff state for brain 
implantation. (b) An ULTS probe in the soft state with integrated chemical delivery function. Inset, 
SEM of the probe tip that shows the outlet of the chemical delivery channel and electrodes. (c) Two 4-
shank probes were assembled to a 3D probe arrays that can be potentially used to record and stimulate 
neurons in a large volume.  
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 The range of tunable bending stiffness was calculated based on the materials’ 
Young’s modulus and the shapes of the probe between the “stiff” and “inflation” state and 
the “soft” and “deflation” state. For a conservative estimation, the expanded shape was 
approximated to be a semi-circle (profile at 30 Psi) with a radius of 52 μm. This resulted 
in a stiffness difference of 5 orders of magnitude between these two states, where the phase 
change contributes ~4 orders of magnitude and shape change contributes to the rest 10-
fold. During real applications, an even larger tunable range can be obtained when a higher 
pressure (60 Psi) is applied to provide a probe with larger cross-section before insertion.  
 
The bending stiffness per width D  depend on its cross-section shape and the 
material properties, as 
Figure 4.8 Characterization of the probe deformation with respect to different Ga injection pressure 
Figure 4.9 Model of neural probes: (a) “Soft” and “flat” state, (b) “Stiff” and “flat” state, (c) “Soft” and 
“inflation” state, (d) “Stiff” and “inflation” state, (e) “Soft” and “deflation” state 
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 𝐷 = ෍
𝐸௜𝐼௜
𝑤
௜
 (1) 
where 𝑤  is the probe width (144 μm) , 𝐸  is the Young’s modulus of material 
(𝐸୐୧୯୳୧ୢିୋୟ୪୪୧୳୫  is ~0 Pa , 𝐸୊୭୰୸ୣ୬ିୋୟ୪୪୧୳୫  is ~10 GPa , 𝐸୔ୈ୑ୗ  is ~1 MPa), and 𝐼  is the 
second moment of area with respect to the neutral axis. It is easier to derive the second 
moment of area with respect to its central axis, and use the parallel axis theorem to derive 
the second moment of area with respect to the neutral axis, as 
 𝐼 = ෍ ቂ𝐼௖௝ + 𝐴௝൫𝑦௖௝ − 𝑦ത൯
ଶ
ቃ
௝
 (2) 
where 𝐴 is the area of the shape, 𝐼௖ is the second moment of area with respect to its 
central axis, 𝑦௖ is the location of its central axis, and 𝑦ത is the location of neutral axis. The 
expression to calculate 𝐴, 𝐼௖ and 𝑦௖ are summarized in the Table 1. The location of neutral 
axis 𝑦ത can be written as 
 𝑦ത =
∑ 𝐸௝𝐴௝𝑦௖௝௝
∑ 𝐸௝𝐴௝௝
 (3) 
Table 1. The area, second moment of area and the central axis location of rectangle 
and semicircle 
The calculation results of five models are shown in Table 2, where the inflated 
shape with solid gallium has the highest bending stiffness per width (1.41×10-4 N·m) for 
tissue penetration and the deflated shape with liquid gallium has the lowest bending 
stiffness per width (1.32×10-9 N·m) to reduce micromotion-induced damage. Therefore, 
Rectangle 𝐼௖ 𝐴 𝑦௖ Semicircle 𝐼௖ 𝐴 𝑦௖ 
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ℎ
2
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the range of tunable stiffness can be as large as 105, where the gallium phase change 
contributes close to 4 orders of magnitude difference (“stiff” and “inflated” vs. “soft” and 
“inflated), while the shape change contributes to the rest 10-folds (“soft’ and “inflation” vs. 
“soft” and “deflation”).  
Table 2. The location of neutral axis and the bending stiffness per width of models 
      
𝑦ത (𝜇𝑚) 13.85 18.42 24.60 43.20 12.56 
𝐷 (N ∙ m) 1.89 × 10ିଽ 2.05 × 10ି଺ 1.56 × 10ି଼ 1.41 × 10ିସ 1.32 × 10ିଽ 
 
4.4 Temperature response of ULTS probes 
To confirm the probe softening temperature at ~ 30 ºC, we inserted an ULTS probe 
into DI water with elevating temperature from room temperature (~ 25ºC) to above 30 ºC. 
DI water was contained in a beaker with stir bar sitting on top of a hotplate with. Probe 
was inserted into the stirred water at room temperature, and showed no deflection at its 
stiff state.  
 
Figure 4.10 Probe softening in stirred and heated water. Below 30 ºC, probe remains stiff indicated by 
the unchanged probe shape. At higher temperature, probe becomes soft and the shape is disturbed by the 
stirring water. Scale bar, 1 mm.  
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4.5 Testing of Self-Implantation Capability in Gel 
We tested the ULTS probes in brain phantoms (0.6% agarose gel), which has 
similar mechanical properties to neural tissues. 9 mm-long ULTS probes can be implanted 
into brain phantoms robustly when filled with Ga at 15 Psi phantom in “stiff” state at room 
temperature (Figure 4.11a), whereas a probe in “soft” state at elevated temperature (T > 
30 ºC) could not remain straight and would deform upon contact with the brain phantom 
surface. A 2-cm long probe, filled with Ga at 60 Psi, can also be implanted into this brain 
phantom in “stiff” state at room temperature (Figure 4.11b) A four-shank ULTS probe 
was also fabricated and implanted into the brain phantom, demonstrating the capability of 
scaling up to multi-shank probe and 3D probe arrays for large volume neural recordings 
(Figure 4.11c).  
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After implantation, the brain phantom was heated up in a water bath to 37 ºC to 
simulate brain temperature recovery. Ga was melted and the stiffening channel was 
deflated by active suction from the inlet of the Ga channel to reduce the bending stiffness 
in “soft” state (Figure 4.12).   
Figure 4.11 Implantation of (a) 9-mm long single-shank probe, (b) 2-cm long single-shank probe, (c) 
1-cm long 4-shank probes in brain phantom (0.6% agarose gel) at room temperature.  
1mm 
Gel 
Water 
25 ºC 
2 mm 
c a 
1mm 
b 
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For comparison, we tested the flexibility of “soft” ULTS probe as well as Si and 
SU-8 based probes with similar dimensions (~150 μm wide and ~50 μm thick) (Figure 
4.13, 4.14). ULTS probe was so flexible that the implanted portion of the probe kept steady 
regardless of the movement of gel in all directions, whereas both Si and SU-8 probes 
created larger wound during the movement of probe bases.  
100μm 
40μ
 
a 
500μm 
Gel 37 ºC 
b 
500μm 
Gel 37 ºC 
100μm 
Figure 4.12 (a) ULTS probes in the “expansion” state. Top, SEM bird view of an ULTS probe tip with 
15 Psi injection pressure. Scale bar, 100 μm Inset, SEM front view shows a deformation of 40 μm. 
Scale bar, 40 μm. Bottom, picture of a probe implanted in a brain phantom with expanded shape. Scale 
bar, 500 μm. (b) ULTS probes in the “deflation” state. Top, SEM bird view of a deflated ULTS probe 
tip. Scale bar, 100 μm. Bottom, picture of a “deflated” probe by active suction of Ga. Scale bar, 500 
μm. 
 62 
 
 
 
ii iii iv v i 1mm 
Gel 
Water 
37 ºC 
Figure 4.13 Pictures of a “soft” ULTS probe in a brain phantom. Probe base was moved in all directions 
to simulate the relative motion between skull and brain. Scale bar, 1 mm.  
a b 
c 
Figure 4.14 Comparison of Si, SU-8 and ULTS probes with similar dimension (50 μm thick) with vertical 
probe movement to simulate the relative brain/skull movement. Si (a) and SU-8 (b) probes followed the 
vertical movement, while ULTS probe (c) remained steady inside the gel without obvious movement. 
Arrows indicate the movement direction.  
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Figure 4.15 Comparison of Si, SU-8 and ULTS probes with similar dimension (50 μm thick) with 500 
μm lateral gel movement to simulate the relative brain/skull movement. Silicon probe tended to keep its 
original position, and created a rectangular wound pattern with the tip scratches a line of ~1000 μm. SU-
8 probe created a cone-shape wound pattern, with the probe anchored at the gel interface. The probe tip 
scratches a line of >1000 μm. While ULTS probe followed the gel movement perfectly without creating 
any visible wound in gel. Arrows indicate the gel movement direction.  
a 
b 
c 
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4.6 Fabrication and Characterization of Biosensors on ULTS probes 
Pt electrodes on ULTS probes were converted into enzymatic biosensors for 
chemical detections. Amperometric electroenzymatic methods for the near real-time 
detection of chemicals, such as neurotransmitters and glucose, have been developed using 
platinum electrodes modified with H2O2-generating oxidase [8], [22], [110], [111]. In the 
presence of H2O2-generating oxidase, the substrate of interests can be converted into H2O2, 
which can be directly electrooxidized by applying anodic potentials on platinum electrodes 
and converted to electrical current signals that can be recorded. Unfortunately, efficient 
oxidation of H2O2 requires a high anodic potential at which electroactive interferents, such 
as dopamine (DA) and ascorbic acid (AA), are also oxidized and thereby contribute an 
undesired amperometric current signal[112]. A layer of poly-m-Phenylenediamine (PPD) 
were electrodeposited in this study to block common interferents (e.g. AA and DA), to 
reduce signals from undesired oxidation reaction.  
Bare Pt electrodes were first tested to characterize the response to H2O2. Before 
acid cleaning process, the sensitivity varies a lot among different electrodes and typically 
have a 0.1-1 nA response to 20 μM H2O2, leading to a poor repeatability of the final 
biosensor performance. It is believed that the unstable and low response of the bare Pt 
electrodes are due to the impurities of the deposited Pt and organics residues on top. 
Therefore, Pt electrodes are routinely cleaned in sulphuric acid (H2SO4) electrochemically 
by scanning the voltage between -0.2 V to 1.3V for 3 cycles vs. Ag/AgCl reference 
electrode and Pt counter electrode in a three-electrode system. After the cleaning process, 
all sensors exhibit a similar response of ~2 nA to 20 μM H2O2. Figure 4.16 compares 
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typical bare Pt sensors with/without acid cleaning. All the sensors were cleaned before 
coatings in this work.  
 
 
We coated the PPD modified Pt electrodes with GluOx to detect the amino acid 
Glut, which is the major excitatory neurotransmitter in the mammalian central nervous 
system and related to many abnormal behaviors apparent in neurological and psychiatric 
disorders[13], [113], [114] (Figure 4.17).  
 
 
Figure 4.16 Bare Pt sensor test for H2O2 sensing before and after acid cleaning process 
Figure 4.17 Schematic diagram of the coatings on a single electrode on the ULTS probe 
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The sensitivity, detection limit and linear range were tested by sequential injection 
of Glut solutions into a stirred PBS buffer. Figure 4.18a shows a representative current 
response of biosensor to Glut with concentrations of 20, 40, 60, 80, 100, 120, 140 and 160 
μM. Figure 4.18b shows the calibration curve for Glut biosensors (n = 4), displaying a 
linear detection range of up to 160 μM (R2 = 0.994) ), which covers the concentrations in 
the physiological range[21]. The Glut sensors coated on ULTS demonstrate a comparable 
performance to silicon based biosensors with the same electrode design[21], [39]. High 
sensitivity of 8.2 ± 1.2 pA/μM and detection limit of 0.39 ± 0.07 μM (n = 4) at a signal-to-
noise ratio of 3 was achieved. At the same time, common interferents in brain extracellular 
fluids, AA and DA, were successfully blocked by the PPD layer (Figure 4.18c), while the 
response of glutamate detection was ~1 s, demonstrating a near real-time sensing capability.  
Using the same process, Pt electrodes were also converted into Glucose sensor to 
show the versatility of the platform. Figure 4.18c shows a representative sensing curve of 
glucose, showing a ~6.5 nA response to 800 μM glucose concentration, which is similar to 
silicon probes.  
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Electrochemical preparation of the sensors, and characterization (sensitivity and 
detection limit) were performed using a Versatile Multichannel Potentiostat (model VMP3) 
equipped with the ‘p’ low current option and low current N’ stat box (Bio- Logic USA, 
LLC, Knoxville, TN, USA). Gel and in vivo experiments were conducted with a 
multichannel FAST-16 potentiostat (Quanteon, LLC, Lexington, KY, USA). 
Amperometric data were collected at 80 kHz and averaged over 0.1 s intervals and further 
processed using moving average filter with 11 input points in MATLAB to remove noise 
at 1 Hz. 
Microelectrodes on ULTS probes were rinsed with DI water followed by 
electrochemical cleaning step with 0.5 M sulfuric acid. Electropolymerization of poly-m-
Figure 4.18 Characterization of Glut sensor. (a) A representative current response of the biosensor to 
Glut. (b) A calibration curve for glutamate biosensor (n = 4) that shows a linear detection behavior in 
the relevant physiological range, < 10-160 μM. Error bars mark the SD. (c) Current response of the 
glutamate biosensor to interferents, glutamate and H2O2. Arrows indicate the sequential injections of 20 
μM Glut, 20 μM Glut, 5 μM DA, 250 μM AA, 20 μM Glut and 20 μM H2O2 
a b
c d 
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Phenylenediamine (PPD) on electrode surface (5 mM m-Phenylenediamine in stirred PBS, 
0.85 V vs. Ag/AgCl, 15 min) was conducted using a standard three-electrode system, 
consisting of a platinum wire auxiliary electrode, a glass encased Ag/AgCl in 3M NaCl 
solution reference electrode (Bioanalytical Systems, Inc., West Lafayette, IN, USA), and a 
platinum working electrode on our ULTS probes. After the PPD deposition, the GlutOx 
solution for enzyme immobilization was prepared by mixing 2 μL GlutOx (250 unit/mL) 
with 3 μL BSA solution (10 mg/mL) containing glutaraldehyde (0.125% v/v). A ~0.1 mL 
drop of the solution was formed on a syringe tip and the drop was gently swiped across the 
microelectrode sites at the probe tip. This procedure was repeated 11 times. The resulting 
Glut sensor microprobe was left to dry overnight in a desiccator at 4 °C. 
In vitro (pre-calibration and post-calibration) and in vivo measurements were 
conducted using a two-electrode system, with a separate microscale IrOx reference 
electrode (0.6 V vs. IrOx). IrOx was electrodeposited onto silicon-based multielectrode 
arrays (MEAs) following the method described by Tolosa et al[21]. Before IrOx deposition, 
electrode surfaces were first modified with Pt nanoparticles to increase the surface area 
following the method described by Boehler et al[115]. The detailed fabrication process was 
described in previous work. Before making measurements, more than 30 min of 
equilibrium time in sodium phosphate buffer (PBS) or ~1 hr of equilibrium time for in vivo 
studies was required for the current detected to approach a constant baseline. 
For in vitro studies, three 20 μL aliquots of glutamate (10 mM) were added to the 
beaker containing 10 mL PBS solution to reach a final glutamate concentration of 20, 40 
and 60 μM glutamate. Additionally, aliquots of the potential interferents, AA (250 μM final 
concentration) and DA (5-10 μM final concentration), were added to the beaker in most 
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tests to determine selectivity for glutamate. A calibration factor based on analysis of these 
data was calculated for each electrode on the ULTS microprobes to be used for in vivo 
experiments.  
 
4.7 Characterization of the microfluidic channel 
As shown in Figure 4.19, the injection behavior of the microfluidic channel was 
tested in a brain phantom (0.6% agarose gel). ULTS probe was connected to a microfluidic 
tubing with preloaded liquid, which was connected to a constant pressure source. The probe 
was then implanted into a brain phantom to simulate the brain environment. Liquid started 
flowing out as soon as we turned on the pressure source, and the time duration for injecting 
all the liquid preloaded in the tubing was recorded. The flow rate was determined by the 
ratio between the preloaded volume and pumping duration. Flow rates at different pumping 
pressure (30-60 Psi) were tested for 3 times to determine the system repeatability. 
 
The chemical delivery function was evaluated by injecting aqueous solution of red 
colored dye into brain phantoms with a pressure source (Figure 4.20a). The flow rate of 
Figure 4.19 Schematic diagram of the liquid pumping system to characterize the chemical delivery 
function  
 70 
 
the PDMS microfluidic channel was measured at various pumping pressures ranging from 
30 Psi to 60 Psi (Figure 4.20b), which demonstrates a linear relationship (R2 = 0.995) 
versus the pumping pressure and high repeatability (n = 3). Therefore, the integrated 
microfluidic channels on ULTS probes are capable of reliable drug delivery. It should be 
noted that the flow rate of the microfluidic channel on ULTS probe is much slower than 
that described in chapter 3, which is due to the smaller channel dimension.  
 
 
4.8 Electrochemical sensing and chemical delivery test in gel 
Next, we tested the integrated functions of electrochemical sensing and chemical 
delivery in an artificial cerebrospinal (aCSF)-brain phantom (0.6% w/v agarose in aCSF), 
by injection and detection of the same chemicals, H2O2 (40 μM) and glutamate (150 μM). 
Local injections of the chemicals were immediately captured by biosensors. Increasing the 
injection volume resulted in higher detection peak, where the duration of rising edges was 
the same as the injection duration (Figure 4.21). The current level starts decreasing when 
1mm 
a b 
Figure 4.20 Fluidic injection in gel. (a) Optical image that demonstrates delivery of liquid (aqueous 
solution with red dye) into a brain phantom (0.6% agarose gel in water). Scale bar, 1 mm. (b) Flow 
rate of the microfluidic channel at different pumping pressures shows a linear relationship versus 
pumping pressure (R2 = 0.995) and high repeatability (n = 3).  
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the injection ends based on pure diffusion. Due to the molecular weight difference between 
H2O2 (34 g/mol) and glutamate (147 g/mol), the signal level of H2O2 decays much faster 
than that of glutamate (~10s vs. ~50s). The results demonstrate the in-vitro functionality of 
the ULTS probe.  
 
 
4.9 In-vivo experiments  
Next, we implanted ULTS probes in rat striatum (A/P +1.0 from bregma, M/L +2.5 
and D/V -5.0) to test their in vivo capabilities. For tests in vivo, male Sprague Dawley rats 
(250–300 mg) were anesthetized with isoflurane and placed in a standard stereotaxic frame 
for surgery. All experimental procedures and surgeries were conducted in accordance with 
the Institutional Animal Care and Use Committee and UCLA.  
In a typical implantation procedure (Figure 4.22), a microscale temperature probe 
(HYP1-30-1/2-T-G-60-SMP-M, Omega Engineering, Inc.) was first inserted under the 
skull (5.0 mm depth) at a site remote from the recording area. Cold sterilized saline (~10 °C) 
was used to moderately cooled down the brain tissue to below 30 °C to keep the probe 
Time (s) 
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Figure 4.21 In vitro testing of chemical delivery and detection of 40 μM H2O2 (a) and 150 μM Glut (b) 
in aCSF brain phantom tissues (0.6% agarose gel in aCSF). Liquid was injected at 60 Psi with injection 
duration of 4.8 s, 2.4 s, 1.2 s, 0.6 s and 0.3 s (Arrows) with 2 mins interval.  
a b 
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straight and stiff throughout the entire implantation track. Then, the ULTS probe with 
microbiosensors, pre-calibrated to glutamate (see above) was unilaterally implanted into 
the right stratum (A/P +1.0 from bregma, M/L +2.5 and D/V -5.0) according to the atlas of 
Paxinos and Watson (4th ed.), typically within a minute to reduce the brain cooling 
duration. In the meantime, the body temperature of rats was kept at 37 ºC by a heating pad 
underneath the body during surgeries. The cooling process typically lasts for 3-5 mins, and 
the temperature recovers to baseline in a few minutes (Figure. 4.23). We confirmed that 
the probe was implanted to the targeted region in striatum by a bright-field microscopy 
image of brain slices (Figure. 4.24).  
 
a b 
Figure 4.22 Optical image of the stereotaxic implantation of a ULTS probe into an anaesthetized rat 
brain. The white, yellow and red arrows indicate the ULTS probe, the cold saline outlet and the 
hypodermic temperature probe, respectively. (b) Optical image of an implanted ULTS probe in a rat 
brain. Arrow indicates the probe. 
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Figure 4.23 A representative brain temperature curve that shows the brain cooling and temperature 
recovery process. Arrows indicate the start and end of the application of cold saline solution (~10 ºC). 
Figure 4.24 Probe insertion into a rat striatum. (a) Bright field image of a brain slice cut along the probe 
insertion direction. The red arrow indicates the implanted position of the probe in the rat striatum, 
evidenced by the wound caused by the acute implantation process. Scale bar: 1 mm (b) Zoomed-in view 
of the brain slice. Scale bar: 0.5 mm 
a b 
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After the implantation of the probe, the temperature probe was removed and the 
microscale IrOx reference electrode was inserted at the same spot for acute electrochemical 
sensing and chemical delivery tests. Animals remained under anesthetic throughout the 
experiment. The entire experiment was conducted inside a Faraday cage. The biosensor 
was connected to the FAST-16 potentiostat and a potential of 0.6 V versus IrOx was applied. 
The electrode signal was allowed to equilibrate to baseline for approximately 30 mins. 
Changes in signals were recorded following pressure ejection of high potassium aCSF or 
L-glutamate by a pressure source (FemtoJet, Eppendorf) at various time intervals. 
Responses were recorded across a range of signal amplitudes by increasing the time of 
pressure ejection (0.3-4.8 s) and thereby increasing the overall volume applied (~1-20 nL). 
We first repeated the same experiment of exogenous glutamate injection and 
detection in vivo to observe the glutamate uptake phenomenon. Glutamate (500 μM in 
aCSF) was injected with various duration to control the injection volumes and each 
injection condition was repeated for three times (Figure 4.25). Unlike the in vitro 
experiments, the in vivo signal level dropped rapidly as soon as the injection ends, and 
typically returns to the baseline level within 3s, which is due to the glutamate uptake by 
surrounding neurons compared with the in vitro slow diffusion based decay (Figure 4.26). 
At the same time, multiple injections under same conditions resulted in nearly identical 
response demonstrated the repeatability of the system for in vivo electrochemical sensing 
paired with neuropharmacology studies. 
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Second, we also observed physiological phenomena by repeated local injections of 
potassium enriched artificial cerebrospinal fluid (100 mM K+ aCSF) to induce glutamate 
release from neurons (Figure 4.27a). Same as reported elsewhere[116] (Figure 4.27b), a 
large glutamate signal was detected followed by an abrupt reduction of induced glutamate 
Figure 4.25 Repeated injection of exogenous 500 μM Glut into the rat striatum region with 2 mins 
interval demonstrating the repeatability of the chemical delivery system. Glut solutions were injected 
at 60 Psi with injection durations of 2.4 s, 1.2 s, 0.6 s and 0.3 s, respectively, as indicated by the 
brackets. 
60Psi, 2.4s 60Psi, 2.4s a b 
Figure 4.26 Comparison of glutamate injection and detection (a) in vitro and (b) in vivo 
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level, presumably due to the depletion of the glutamate storage in neurons. The signal level 
was slightly recovered after 25 mins recovery period without any stimulation. It should be 
noted that, the Glut concentration recorded by the ULTS probe is much higher than that of 
the previous report (~160 μM vs ~30 μM), which is presumably due to the close distance 
between the liquid outlet and sensing electrodes (<50 μm, edge to edge). Therefore, 
together with the previous in vivo experiment, multifunctional ULTS probes demonstrate 
their feasibility in live rodents similar to Si based devices, while the reduced stiffness and 
dimension would greatly minimize brain damages. 
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4.10 Long-term survival experiment and immunohistochemistry 
As described in the introduction, neural probes made from softer substrate material 
has shown improved implant/tissue integration with reduced foreign body reaction and 
neuroinflammation response using PVA[68], Parylene-C[99] and etc[74]. However, no one 
has tested the immune response to PDMS-based ultra-soft neural probe. Therefore, we 
implanted both an ULTS probe and a size-matched silicon probe (~30 μm thick) into a rat 
striatum bilaterally. The surgery procedure is similar to the case of acute experiment. 
Figure 4.27 (a) Repeated injection of potassium enriched artificial cerebrospinal fluid (100 mM K+ 
aCSF) in rat striatum to induce Glut release with 2 mins interval. There was an abrupt reduction of 
induced glutamate level following the first stimulation, which was partially recovered after a prolonged 
period (25 mins) free from stimulation. Solutions were injected at 60 Psi with an injection duration of 
4.8s. (b) Same experiment demonstrated by Walker et al. [102] showed a similar phenomenon.  
a 
b 
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Instead, more holes were drilled with one for the implantation of silicon probe on the 
contralateral hemisphere, and rest of them for screws to anchor the probes. The immune 
response was evaluated at different time points (2 weeks, 4 weeks and 8 weeks) by 
immunohistochemistry with procedures described below.  
Rats with implanted ULTS and silicon probes were anesthetized with pentobarbital 
and perfused with 1x PBS (2 mg heparin/100 mL) followed by ice-cold 4% 
paraformaldehyde in phosphate buffered saline (PBS) transcardially before decapitation. 
Brains were dissected, postfixed for ~12 hrs at 4 °C with 4% paraformaldehyde in 
phosphate buffered saline (PBS). Then, the 4% paraformaldehyde solution was replaced 
by 30% sucrose in PBS at 4 °C. After 2 days, the brain samples were cut into 40 µm sections 
for immunostaining using LEICA CM 1950 cryosectioning instrument. Horizontal brain 
tissue sections were washed three times in 1× PBS (10min/each) and blocked using a 
blocking solution consisting of 0.1% Triton and 5% donkey serum in 1× PBS for 2 h at 
room temperature. Slices were then incubated with the primary antibody, rabbit anti-GFAP 
(1:1000 dilution; Millipore) containing 0.1% Triton and 5% donkey serum overnight at 
4 °C. After incubation, slices were rinsed 3 times in 3× PBS (10min/each) and 1 time with 
1× PBS (10min/each) before they were incubated with the secondary antibodies, Alexa 
Fluor 488 donkey anti-rabbit (1:100 dilution; Invitrogen) diluted with 2% donkey 
serum/0.1% Tween in 1x PBS for 2 h at room temperature. Slices were then washed 3 times 
with 0.1% Tween in 1× PBS (10min/each) and 1 time with 1× PBS (10min/each)  before 
they were mounted on glass slides with coverslips using Aqua-Mount (Richard-Allan 
Scientific). The slides remained in the dark at 4 ºC before microscopic imaging. 
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 Fluorescence images of the samples were acquired on an Axio Scope.A1 (Zeiss) 
microscope with AxioCam MRm (Zeiss) camera. Exposure time and other imaging 
parameters were held constant for all samples. Representative fluorescence images were 
slightly enhanced using ImageJ to improve visual display. 
Following image acquisition, pixel-based image intensity analytics were performed 
using a modified MATLAB program based on published custom MATLAB script 
I.N.T.E.N.S.I.T.Y.[67], [117]. In short, an ellipse was drawn to locate the implant-tissue 
interface. The fluorescence intensity was quantified in 5 μm bins of expanding concentric 
ellipses around the implantation site up to 300 μm and normalized against the baseline 
intensity, which was defined as the average intensity in the interval of 500-550 μm away 
from the center of the implantation site. Statistical analyses were performed using Prism 
5.0 (GraphPad Software, USA).  
Immunolabeling of GFAP was used to monitor astrocytes[118]. At 2 and 4 weeks 
post-implantation, GFAP intensity around the silicon probe is significantly higher than that 
around the ULTS probe, and extended further away from the implant, showing a denser 
astrocytic scar tissue formed around the silicon probe (Figure 4.28, 4.29). GFAP as well 
as NeuN and ED1 labeling will be applied to longer time points to continue the 
investigation of the immune response to ULTS and silicon probes. However, the 
preliminary results from the 2 and 4-week GFAP staining show similar response to other 
literature[68], which has a lot of promise to reduced inflammation response in longer time.  
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a b 
Figure 4.28 Immunohistochemical analysis of the astrocytic scar at 2 weeks. (a) ULTS probes vs. (b) 
silicon probes with GFAP staining two weeks after probe implantation. Scale bar, 50 μm.  
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Figure 4.29 Immunohistochemical analysis of the astrocytic scar after 4 weeks of implantation of a ULTS 
probe and a size-matched Si probe showing reduced scar encapsulation around the ULTS probe. (a,b) 
Representative fluorescence microscopy images of GFAP expression around a ULTS probe and a Si 
probe respectively. Scale bar, 100 μm. (c) There are less astrocytes surrounding ULTS compared to 
silicon probe. Normalized fluorescence intensity of GFAP expression from the implant-tissue interface 
to 300 μm away, with 5 μm bin size distance (Silicon n = 10 slices, ULTS n = 10 slices; Two-way 
ANOVA, probe type and distance interaction: F(59,1080) = 4.95, p <0.0001; Bonferroni post-test for 
distance at 10-30 μm: p < 0.0001, distance at 35 μm: p<0.001). Gray shadow denotes the significant 
difference between the ULTS and Silicon probes. 
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4.10 Discussion 
With the advancements of understandings in neural science, deeper and more 
complicated research questions are raised in academia, while clinically many brain-related 
diseases such as Parkinson disease can be treated by deep-brain stimulation (DBS). Hence, 
there is a huge demand for minimally invasive devices to be implanted deep into the brain 
to record and stimulate neural activities. Here we presented ULTS probes that meet this 
demand. With the ultra-large tunable stiffness range, ULTS probes are stiff enough to be 
implanted deep into the brain without temporary carriers, and become extremely soft after 
implantation so that tissue damage and immune response can be reduced. In addition to the 
phase change of Ga between solid and liquid state, the stiffness was enhanced by increasing 
the cross-section area by filling in Ga at higher pressure. When filled at the maximum 
pressure of 60 Psi, the ULTS probe could penetrate 2 cm deep into brain phantom, which 
could be potentially used in larger animals such as primates. Regular 9 mm-long ULTS 
probes with “flat” shape (pressure released after Ga filling) was capable of penetrating 
brain phantoms, however 15-30 Psi was usually applied to inflate the probe to improve the 
robustness of the implantation process. When higher stiffness is needed for deeper 
penetration, the stiffening channel could be fabricated using elastomers with higher 
stretchability to further increase the probe deformation under same filling pressure.  
  It should be noted that the calculation of tunable stiffness range is conservative. 
On the stiff side, semicircle shape was used to simplify the calculation, while in practice 
the stiffening channel can be filled with larger pressure, e.g. 60 Psi, leading to a major arc 
shape which is larger than semicircle. On the soft side, the stiffening channel can be 
contracted with active suction which reduces the probe thickness from 30 μm to ~20 μm, 
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that further lower the bending stiffness by a factor of 3.375 due to the cubic scaling. 
Therefore, the tunable stiffness range can be larger than 5 orders of magnitude based on 
the current ULTS probe design. In addition, compared to other self-implantation 
approaches, ULTS probes, with similar dimension, can be implanted much deeper. Despite 
the higher modulus of Ga (10 GPa vs. 2-5 GPa[96], [98], [119]), the tip of the unique 
“dolphin head” structure (Figure 4.30) after expansion remains sharp in 3D and likely 
reduces the force needed to penetrate the brain surface. With sharper tips, more tissues 
would be pushed to the sides instead of squeezed along the penetration direction to reduce 
initial tissue damages.  
 
  The layer-by-layer thin film transfer process has the intrinsic advantage of creating 
microchannels, which is intricate using conventional MEMS fabrication. As demonstrated 
in this work, microchannels can be utilized for electrical interconnects and fluidic delivery, 
moreover, they can be easily converted into optical waveguides for optogenetics 
applications when filled with higher refractive index fluid. In this work, the number of 
Figure 4.30 SEM image of the “dolphin head” structure of the ULTS probe tip, forming a 3D 
sharp tip.  
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electrodes are limited by the large electrode size required by electrochemical sensing but 
not the electrical interconnects. On the contrary, the linewidth of microchannels are defined 
by lithography, meaning it can be scaled up to match the electrodes count of conventional 
probes. Although electrophysiology recording and electrical stimulation were not 
performed in this study, the impedance of the electrodes, 21.4 ± 1.50 kΩ (n = 5) at 1 kHz 
(Figure 4.30a), is at least identical to Si based probes with platinum electrodes due to the 
highly conductive liquid metal interconnect. Moreover, rough Pt surface (Platinum 
grass[115]) can be easily deposited electrochemically to increase the effective surface area 
and lower the impedance to 6.74 ± 0.49 kΩ (n = 3) at 1 kHz (Figure 4.30b) and resulted 
in a charge storage capacity of 4.5 mC/cm2 (Figure 4.30c) and exhibited a typical Pt 
electrode property (Figure 4.30d). Therefore, we believe that with proper electrode design, 
ULTS probes can be easily converted for electrophysiology recording and electrical 
stimulation applications.  
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  To implant ULTS probes, selective brain cooling method was used without 
altering the core temperature. The practice has been widely used to inhibit neural activities 
and alter behaviors in research labs, as well as clinically used as therapeutic tool in cardiac 
arrest, hypoxic ischemic neonatal encephalopathy, stroke and brain trauma[120]. With 
a b 
c d 
Figure 4.31 Electrical characterization of electrodes. (a) A representative electrochemical impedance 
spectroscopy (EIS) measurement of a regular Pt electrode of the ULTS probe in saline solution (pH 
7.4). The impedance of the regular electrodes, 21.4 ± 1.50 kΩ (n = 5) at 1 kHz, which is similar to the 
Pt electrodes on Si probes.  (b) The impedance decreases to 6.74 ± 0.49 kΩ (n = 3) at 1 kHz with the 
electrodeposition of rough Pt grass surface. (c) Cyclic Voltammetry (CV) measurement of the Pt grass 
coated electrodes in saline (pH 7.4) in the range of -1 V to 1 V vs. Ag/AgCl, with a potential scan rate 
of 100 mV/s. Charge storage capacity is determined by the integral area of CV curve/(2 × scan rate) = 
2.54 μC. (d) CV measurement of the Pt grass coated electrodes in a diluted sulfuric acid solution (0.5 
mM) in the range of -0.3 V to 1.1 V vs. Ag/AgCl, with a potential scan rate of 100 mV/s. The 
measurement reveals a typical Pt electrode response with high current density.  
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extensive studies, brain appears to tolerate temperature reduction (0-36 ºC) well for 
relatively brief period (1-3h), which is fully reversible without significant 
consequences[121]–[124]. In this work, survival surgeries were performed on 7 rats with 
ULTS probes implanted with procedures described above. 6 rats survived and behaved 
normally after surgery, while 1 rat died right after anesthesia before surgery. The results 
confirm that brief period (~10 mins) of selective brain cooling process shows no observable 
effect on rats. In the current implantation protocol, a separate temperature probe is used to 
monitor the brain temperature, which would increase the surgery complexity and 
invasiveness. In the future, temperature sensor can be integrated by patterning platinum 
filament on the probe tip to monitor the brain temperature for both implantation purpose 
and biological studies.   
Of note is that ULTS is a platform technology that allows the integration of multiple 
functional modules on compact and elastic probes that can self-penetrate deep into a brain. 
Although functions of electrochemical sensing and fluid delivery are shown in the work, 
these are still proof-of-concept demonstration. The optimization of these functional 
modules will most likely be based on different specific applications in the future, which 
will be beyond the scope of this work. For example, the enzyme coating needed for 
electrochemical sensing may degrades after 7 days, and long-term electrochemical sensing 
on ULTS is not yet ready. Other optimization such as surface coating the microfluidic 
channels might also be needed for delivery of drug that may be absorbed on the channel 
walls through non-specific absorption. 
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Conclusion 
Electrical-based neural recording including electrochemical sensing of chemicals 
and extracellular electrophysiological recording is one the most important tools to detect 
neuronal activities in deep brain regions with minimal invasiveness. Neural probes have 
been developed for over several decades, however, the existing devices are far from perfect. 
A great amount of effort has been put to improve the current platform in the directions such 
as (1) increasing the functionalities of an integrated neural probe to enable more 
complicated neuroscience research, (2) improving the biocompatibility for stable long-term 
recordings, and (3) increasing the number of simultaneously recorded neurons. The works 
presented here aimed to develop innovative neural probes that tackle the first two problems.  
The work described in Chapter 2 presented silicon neural probes with integrated 
optical waveguides and electrochemical sensors. By using ultra-thin silicon nitride 
waveguides and grating couplers, the light stimulation zone was well matched to the 
sensing zone. The probe was validated by the successful detection of the light-induced 
glutamate release in rats.  
 In chapter 3, we demonstrated silicon probes with integrated chemical delivery 
channels and electrochemical sensors. An innovative PDMS thin-film transfer process was 
developed to transfer microfluidics channels to existing silicon probes as an add-on 
function. Microfluidics channels were integrated with two silicon probe designs, including 
the optogenetics probes developed in chapter 2 and the conventional silicon probes for 
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biosensing. The latter case was validated in vivo by injection and detection of exogenous 
glucose in rat striatum.  
In chapter 4, we aimed to improve the longevity of intracortical implants by 
developing a PDMS-based ultra-soft neural probe to minimize the mechanical mismatch 
and micromotion between the implants and brain tissue. To implant the highly flexible and 
soft probe into brain, we invented a strategy of using liquid metal (Ga) to tune its 
mechanical stiffness from extremely stiff for deep brain implantation to extremely soft to 
reduce brain damage. At the same time, Ga was also used as electrical interconnects 
without any adhesion issue. The probe was designed with a microfluidic channel for 
chemical delivery function. Acute in vivo testing validated the functions of electrochemical 
sensing and chemical delivery of the new device. Probes were implanted in animals for 
longer time and showed reduced scar encapsulation around the soft PDMS probe.  
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Appendix A 
Fabrication process for PDMS probes with electrodes 
 
 General photolithography process 
AZ 5214: 
Vapor deposition of adhesive layer HMDS for 3min 
Spin coating  
step 1: rate 500 rpm, ramp 500 rpm/s, 5 sec 
step 2: rate 3000 rpm, ramp 1000 rpm, 30 sec 
Soft bake 100℃, 1 min 
Exposure 9.5 sec;  
Develop AZ400K 1:4 
Hard bake 120℃, 2 min 
Descum using technics (500 mTorr, 80 W, 1 min)  
 
AZ 5214 IR: 
Vapor deposition of adhesive layer HMDS for 3min 
Spin coating  
step 1: rate 500 rpm, ramp 500 rpm/s, 5 sec 
step 2: rate 4000 rpm, ramp 1000 rpm, 30 sec 
Soft bake 90℃, 2 min 10 sec;  
Exposure 3 sec 
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Post bake 128℃ 30sec 
Flood exposure 25 sec (longer than 16.8 sec should be fine) 
Develop AZ400K 1:3 or 1:4 
Hard bake at 120℃ 2 min or dehydration bake for lift off process at 50℃  5 min 
Descum using technics (500 mTorr, 80 W, 1 min)  
 
AZ 4620: 
Vapor deposition of adhesive layer HMDS for 3min 
Spin coating  
step 1: rate 500 rpm, ramp 500 rpm/s, 5 sec 
step 2: rate 2500 rpm, ramp 1000 rpm, 30 sec 
Soft bake 100℃, 2 min;  
Exposure 25 sec  
Develop AZ400K 1:3 or 1:4 
Hard bake at 120℃ 2 min or dehydration bake for press through structure at 50℃ 
5 min 
Descum using technics (500 mTorr, 80 W, 1 min)  
 
1. First insulation layer  
 Grow 1um thick thermal oxide 
 Pattern oxide layer 
i. Use AZ 5214 to transfer patterns from mask  
ii. BOE isotopically etch oxide for 10 min 
 Caution: This step should be performed by a continuous 
etching of oxide or wafers should stay in liquid all the time. 
Otherwise, the sidewalls of the undercut area could be quite 
rough. 
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 Caution: Use Nanospec recipe 1 (oxide on silicon) to 
measure remaining oxide thickness. Recipe 7 (thin oxide on 
silicon) sometimes does not show accurate thickness and 
hence don’t just rely on the measurement data. Carefully 
inspect using Microscope.  
 Caution: wash wafers for at least 5 cycles and spin dry   
iii. Remove PR using Matrix (250℃, 3min) 
 
2. E-beam deposition of Cr/Pt/Cr films 
 Pattern electrode  
i. Use AZ 5214 IR to transfer patterns from mask  
 Caution: make sure develop just right by checking 
alignment mark 
 Caution: Do dehydration bake at 50℃ for 5 mins instead of 
hard bake at 120℃ to prevent PR reflow  
 Caution: Descum before e-beam evaporation (technics 500 
mTorr, 80 W, 1 min) 
 E-beam evaporation  
i. Cr/Pt/Cr = 20 nm/ 100 nm/ 50 nm  
ii. Deposition rate = 1 Å/s 
 Caution: Chromium film can’t be thicker than 50 nm. PR 
could be detached from the surface during the process 
 Metal film Lift off  
i. Immerse wafers in acetone bath for 2 hours  
ii. Ultrasound in acetone for 5 secs for 3 times in 3 different beakers 
and rinse with methanol, IPA, and DI water 
 Caution: Keep wafers immersed in solution while handling, 
to prevent redeposit of metal or debris onto wafers  
 Optional: Oxygen plasma using Technics, Matrix, or Tegal 
can be applied to enhance adhesion for later on silicon 
oxide deposition     
 
3. Second insulation layer  
 Deposit silicon oxide 
i. Use STS-PECVD to deposit a total of approximate 400 nm oxide 
layer using recipe 5LFSO by two runs of 7 min 35 sec  
 Caution: Clean chamber when accumulated thickness is 
more than 8 μm. Rotate wafer during deposition process to 
eliminate pinholes   
 Caution: record thickness of oxide film 
 Pattern silicon dioxide  
i. Use AZ 5214 to transfer patterns from mask  
ii. Use AOE recipe OXIDAPIC to etch oxide for at least 1 min 35 
sec  
iii. Remove PR using Matrix (250℃, 3min) 
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4. First PDMS thin film 
i. Use AZ 4620 to pattern vias  
 Caution: Do dehydration bake at 50℃, 5min, to prevent PR 
reflow 
 Caution: Cover 2 inch area with PDMS and remove outer 
PR for thin film press through process 
 Caution: Descum using Technics (500 mTorr, 80 W, 1 min) 
 Caution: Keep it in room temperature for 4 hours after 
descum 
ii. Make PDMS thin film  
 Prepare PDMS 10:1 with platinum 0.6x~1x  μL   
 Ex. 10g PDMS base : 1g curing agent : 0.6-1μL 
platinum 
 Oxygen plasma using Technics (500 mTorr, 80 W, 30 sec) 
 Pour uncured PDMS and covered with reused silane-coated 
glass 
 Degas at lab and press followinging standard thin film 
process   
 Wait until PDMS fully cured  
iii. Remove PDMS residue  
 Use Oxford RIE recipe pdms_xm to etch PDMS for 3 mins 
or longer. Since the etching rate differs among the areas, 
PDMS film becomes nonuniform, which prevents the 
second thin film bonded successfully.  Hence, more than 5 
mins etching time is not recommended.  
 Caution: Make sure the residue has been etched or taped off 
by inspecting if there is light interference pattern among 
those areas 
iv. Remove AZ 4620 in acetone  
 Caution: If there is PR enclosed by PDMS residue, PR 
could still stay inside after the cleaning process, which 
becomes stubborn and hard to be removed. 
 Caution: Make sure all residual PDMS film has been taped 
off  
v. Etch oxide  
 Use AOE recipe oxidapic for at least 1 min 35 sec. Make 
sure the oxide layer has been removed thoroughly 
 Or use Oxford RIE recipe oxide_s for two runs of 7 min 30 
sec   
 Caution: Oxygen plasma using Technics (500 mTorr, 80 W, 
1 min) to remove organics deposited during AOE   
 Second PDMS thin film (wires) and third PDMS thin film (stiffening 
channels) 
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i. Use aligner bonder to pre-align PDMS film(s) on silicon wafer 
with another PDMS film carried by a PDMS buffer, a glass slide, 
and a plastic frame 
 Caution: Fix bottom substrate and top film with gap of 100 
um. Make sure the gaps at left and right alignment marks 
are similar by checking the focal planes  
ii. Do oxygen plasma bonding using Technics (500 mTorr, 80 W, 30 
sec)  
 Caution: If there is dust deposited on film, use tape to pick 
it up and prevent tape to contact films directly 
iii. Use aligner bonder to bond the PDMS film(s) on silicon wafer 
with the PDMS film carried by the PDMS buffer, glass slide, and 
plastic frame 
 Caution: Decrease gap by 30 um each time and turn off 
vacuum pump when two films contact   
 Caution: Gently and evenly squeeze the films to make sure 
the bonding is okay under microscope. Bake in oven at 
70℃ for at least 1 hour for transfer of second layer and 2 
hours for transfer of third layer 
iv. Remove carriers  
 Remove plastic frame, glass, and PDMS buffer step by step 
 Caution: Be careful when removing PDMS buffer. To 
prevent cracking of films, silane treatment on thin films 
before making PDMS buffer is needed. When the width of 
suspending membrane is wider than 50 um, 1 uL silane 
vapor coating (10 min vacuum and 10 min coating) is 
recommended.   
 Caution: Make sure there is no residual PDMS films at 
inlets and edges of probes  
 Adapter 
i. Punch holes  
 Use 0.5 mm puncher to drill holes on adapter from the side 
with inlets patterns. Carry the adapters by glass slides.  
 Caution: The surfaces of adapters might have silane residue 
transferred from silane-coated glass slide. Use tape to 
remove it as much as possible 
ii. Do oxygen plasma bonding using Technics (500 mTorr, 80 W, 30 
sec)  
 Bake at 70℃ for at least 4 hours 
 Caution: Test bonding strength. If the bonding wasn’t good, 
use spacers to separate unbonded areas and do oxygen 
bonding again 
 
5. Gallium injection  
 Wires 
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i. Fill liquid gallium into channels at the same time 
 Caution: Make sure liquid gallium fills into vias 
ii. Solidified liquid gallium under atmosphere pressure 
 Use solid gallium to initial solidification process 
 Caution: Ice could be used to increase the solidifying speed 
 Stiffening channel  
i. Fill liquid gallium into channel  
 Caution: pump air into drug delivery channel to prevent 
collapse due to expansion of stiffening channel  
ii. Solidified liquid gallium under 5-60 psi 
 Use solid gallium to initiate solidification process 
 Caution: 15-30 psi is recommended for gel and brain 
insertion of <1cm long probe. 60 psi is needed for 2cm 
long probe and to check the insertion trace in brain 
 Caution: Ice is used to increase the solidifying speed 
 
6. Probe releasing using xenon difluoride (XeF2) etching  
 Cover adapters with PI films or PDMS to prevent the etching of PDMS 
under the adapter  
 Do 120 pulses of etching: etching pressure 1000 mTorr-1500 mTorr, 
etching time 30 sec, and purging time 10 sec 
 Caution: Do not open the valve all the way to prevent 
instant high heat generated at the beginning of each pulse 
 Caution: Do 5 pulses of etching to test if exposed silicon 
can be etched. If there is no etching of silicon, try to do 
oxide etching using Technics (150 mTorr CF4, 30 mTorr 
O2, 100 W, 10 sec) 
 Caution: Make sure probes are released. Total undercut 
should be more than 330 μm and one can see probes might 
tilt or lift when being released totally 
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